Craig Mayer, Nick WIlliams, Vojtech Huser
Lister Hill National Center for Biomedical Communications, National Library of Medicine, NIH, Bethesda, MD

See the full regCTG repository at https://github.com/lhncbc/CRI/tree/master/regCTG

To return to the list of conditions and view other reports go to https://lhncbc.github.io/CRI/regCTG/regCTG-condition_report_links.html


Study Counts

Type Study_count
Total_Studies 444
interventional 401
Observational 41
Registry 2

Studies over Time by Start Date

```

Interventional Trials

Intervention Type

intervention_type Study_Count
Drug 157
Drug|Radiation 50
Drug|Other 24
Biological|Drug|Procedure 20
Drug|Procedure|Radiation 20
Biological 18
Drug|Procedure 16
Radiation 14
Biological|Drug|Procedure|Radiation 10
Biological|Drug 9
Biological|Procedure 8
Procedure|Radiation 7
Biological|Drug|Radiation 4
Drug|Genetic|Other|Procedure|Radiation 4
Other 4
Procedure 4
Drug|Genetic|Other 3
Biological|Other 2
Device 2
Drug|Other|Procedure 2
Drug|Other|Procedure|Radiation 2
Behavioral 1
Behavioral|Drug 1
Behavioral|Other|Procedure 1
Biological|Drug|Other|Procedure|Radiation 1
Biological|Genetic|Other 1
Biological|Other|Procedure 1
Biological|Procedure|Radiation 1
Device|Drug 1
Diagnostic Test 1
Dietary Supplement|Drug 1
Dietary Supplement|Drug|Procedure 1
Drug|Genetic|Other|Procedure 1
Drug|Genetic|Procedure|Radiation 1
Drug|Other|placebo 1
Drug|Other|Radiation 1
Drug|placebo 1
Drug|placebo|Radiation 1
Genetic|Other|Radiation 1
Other|Procedure 1
Other|Procedure|Radiation 1
placebo|Procedure 1

Count of Studies by Intervention (normalized and mapped)

Interventions over Time

Yearly studies for each intervention by start date

Studies by Country

Country Study_Count
United States 267
United States|Canada 25
NA 10
United States|Australia|Canada 8
United States|Puerto Rico 8
Canada 6
United Kingdom 6
France 5
United States|Australia|Canada|Netherlands|New Zealand|Puerto Rico|Switzerland 5
Switzerland 4
Ireland|United Kingdom 3
United States|Australia 3
United States|Australia|Canada|Netherlands|New Zealand|Switzerland 2
United States|Australia|Canada|Netherlands|Puerto Rico|Switzerland 2
United States|Australia|Canada|New Zealand|Puerto Rico|Switzerland 2
United States|Canada|Netherlands|Puerto Rico|Switzerland 2
Argentina 1
Argentina|Canada|Italy|Netherlands|Spain|Sweden|United Kingdom 1
Australia 1
Australia|Austria|Belgium|Canada|Egypt|France|Germany|Hungary|Israel|Italy|Luxembourg|Netherlands|New Zealand|Portugal|Singapore|Spain|Sweden|Switzerland|United Kingdom 1
Australia|France|Germany|Netherlands|Spain|Switzerland|United Kingdom 1
Austria|Belgium|Croatia|Denmark|France|Germany|Italy|Norway|Poland|Portugal|Switzerland|United Kingdom 1
Austria|Belgium|Denmark|Finland|France|Germany|Hungary|Italy|Netherlands|Portugal|Sweden|United Kingdom 1
Austria|Belgium|Finland|France|Germany|Hungary|Italy|Netherlands|Portugal|Sweden|Switzerland|United Kingdom 1
Austria|Belgium|France|Germany|Italy|Netherlands|Switzerland|United Kingdom 1
Austria|Belgium|France|Italy|Netherlands|Switzerland|United Kingdom 1
Austria|Belgium|Germany|Italy|Netherlands|Portugal|Switzerland|United Kingdom 1
Austria|Canada|France|Germany|Italy|Netherlands 1
Austria|France|Greece|Israel|Italy|Netherlands|Portugal|Switzerland 1
Austria|Germany|Sweden|Switzerland 1
Belgium|France|Germany|Italy|Netherlands|Portugal|Slovakia|Switzerland|United Kingdom 1
Belgium|France|Germany|Italy|Netherlands|Spain|Switzerland|United Kingdom 1
Belgium|France|Italy|Netherlands|Spain|Switzerland 1
Belgium|France|Italy|Netherlands|United Kingdom 1
Belgium|Germany|Italy|Netherlands|Switzerland 1
Canada|Germany|Japan|Netherlands 1
Canada|United States 1
Germany 1
Germany|Netherlands|Sweden 1
Japan 1
Korea, Republic of 1
Norway 1
Spain 1
Sweden 1
United States|Australia|Belgium|Canada|France|Germany|Israel|Italy|Netherlands|Spain|Switzerland|United Kingdom 1
United States|Australia|Brazil|Canada|France|Germany|Hong Kong|Israel|Netherlands|Norway|Poland|Russian Federation|Spain|Sweden|United Kingdom 1
United States|Australia|Canada|New Zealand|Switzerland 1
United States|Australia|Canada|Puerto Rico 1
United States|Australia|Canada|Puerto Rico|Switzerland 1
United States|Australia|France|Netherlands|Switzerland 1
United States|Austria|Belgium|Canada|France|Netherlands|Switzerland 1
United States|Canada|Israel 1
United States|Canada|Palau 1
United States|Canada|Puerto Rico 1
United States|France 1
United States|France|Italy|Spain|United Kingdom 1
United States|France|Korea, Republic of|Spain|United Kingdom 1
United States|Spain 1
United States|Taiwan 1

Sites per Study

Site_count Study_Count
1 157
2 30
3 17
4 9
5 6
6 5
7 7
8 11
9 22
10 15
11 10
12 8
13 5
14 2
15 1
16 1
17 3
18 3
19 3
20 1
21 8
22 6
23 3
24 2
25 1
26 2
28 1
30 1
35 1
36 2
37 1
38 1
39 2
40 1
41 1
43 1
47 1
54 1
56 3
59 1
60 1
65 1
71 1
74 1
76 1
78 1
89 1
92 1
95 1
106 3
107 1
109 1
110 1
111 1
113 1
114 1
116 1
117 1
118 3
132 1
143 1
145 1
150 1
161 1
165 1
168 1
178 1
204 2
207 1
226 1
228 1
230 1
235 1
236 2
237 1
257 1
260 1
261 1
351 1

Phase

Phase Study_Count
Phase 2 152
Phase 1 135
Phase 1/Phase 2 54
Phase 3 29
N/A 24
Early Phase 1 4
Phase 2/Phase 3 2
Phase 4 1

Number of Arms

Number_of_Arms Count_of_Studies
1 138
2 46
3 13
4 9
5 5
6 1
7 1
8 2
12 1
NA 185

Enrollment Metrics by Phase

Measure Early.Phase.1 N.A Phase.1 Phase.1.Phase.2 Phase.2 Phase.2.Phase.3 Phase.3 Phase.4
Min. 14.00 1.0000 1.00000 6.00000 4.00000 114 1.0000 24
1st Qu. 14.75 10.0000 18.00000 35.00000 35.00000 178 159.0000 24
Median 17.50 20.0000 30.00000 60.00000 54.00000 242 350.0000 24
Mean 17.25 228.5217 61.30392 79.31707 93.29457 242 354.6667 24
3rd Qu. 20.00 73.0000 38.50000 116.00000 100.00000 306 520.0000 24
Max. 20.00 3417.0000 3000.00000 279.00000 1500.00000 370 1173.0000 24

Trial Group Type

group_type Group_Count
Experimental 314
NA 185
Active Comparator 36
Other 13
No Intervention 5
Sham Comparator 2
Placebo Comparator 1

Intervention Model

intervention_model Study_Count
Single Group Assignment 174
NA 164
Parallel Assignment 52
Sequential Assignment 7
Crossover Assignment 3
Factorial Assignment 1

Primary Purpose

primary_purpose Study_Count
Treatment 365
Supportive Care 15
Diagnostic 13
Other 4
Basic Science 1
Prevention 1
Screening 1
NA 1

Observational Studies

Studies by Country

Country Study_Count
United States 30
NA 6
France 1
United Kingdom 1
United States|Australia|Canada 1
United States|Australia|Canada|New Zealand|Puerto Rico|Saudi Arabia 1
United States|Canada|Puerto Rico|Switzerland 1

Sites per Study

Site_count Study_Count
1 28
2 2
3 1
9 2
10 2
31 1
36 1
38 1
61 1
110 1
228 1

Enrollment Metrics

Measure Observational
Min 10.000
1st Qu 56.000
Median 90.000
Mean 1355.659
3rd Qu 352.000
Max 33000.000

Observation Model

observational_model Study_Count
Case-Only 16
Cohort 13
NA 8
Case-Control 2
Case Control 1
Other 1

Time Perspective

time_perspective Study_Count
Prospective 24
Retrospective 8
NA 7
Cross-Sectional 2

Registries

Studies by Country

Country Study_Count
China 1
United States 1

Sites per Study

Site_count Study_Count
1 1
37 1

Enrollment Metrics

Measure Registries
Min 1500.00
1st Qu 2139.75
Median 2779.50
Mean 2779.50
3rd Qu 3419.25
Max 4059.00

Registry Model

observational_model Study_Count
Cohort 2

Time Perspective

time_perspective Study_Count
Cross-Sectional 1
Prospective 1

Follow-up

target_duration Study_Count
1 Year 1
36 Months 1

Overview of Studies

Interventional Trials

#If less then 500 trials

nct_id brief_title link overall_status source primary_completion_date
NCT04094610 A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations https://ClinicalTrials.gov/show/NCT04094610 Recruiting Turning Point Therapeutics, Inc. 2022-12-31
NCT03698994 Ulixertinib in Treating Patients With Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With MAPK Pathway Mutations (A Pediatric MATCH Treatment Trial) https://ClinicalTrials.gov/show/NCT03698994 Recruiting National Cancer Institute (NCI) 2025-12-31
NCT03323034 Pevonedistat, Irinotecan Hydrochloride, and Temozolomide in Treating Patients With Recurrent or Refractory Solid Tumors or Lymphoma https://ClinicalTrials.gov/show/NCT03323034 Recruiting Children’s Oncology Group 2021-12-01
NCT03270059 Gadolinium and Ferumoxytol MRI in Diagnosing Patients With Abnormalities in the Central Nervous System https://ClinicalTrials.gov/show/NCT03270059 Recruiting OHSU Knight Cancer Institute 2022-08-15
NCT03245151 Study of Lenvatinib in Combination With Everolimus in Recurrent and Refractory Pediatric Solid Tumors, Including Central Nervous System Tumors https://ClinicalTrials.gov/show/NCT03245151 Recruiting Eisai Inc. 2022-05-31
NCT03206021 Treatment of Children With Recurrent Refractory Brain/Solid Tumors and Recurrent Ependymoma https://ClinicalTrials.gov/show/NCT03206021 Recruiting The Hospital for Sick Children 2021-07-01
NCT03188354 Diagnostic Assessment of 18F-fluciclovine and 18F-FDG -PET/MRI of Primary Central Nervous System Lymphoma https://ClinicalTrials.gov/show/NCT03188354 Recruiting Norwegian University of Science and Technology 2021-12-31
NCT03150862 A Study Assessing Pamiparib With Radiation and/or Temozolomide (TMZ) in Subjects With Newly Diagnosed or Recurrent Glioblastoma https://ClinicalTrials.gov/show/NCT03150862 Active, not recruiting BeiGene 2021-06-30
NCT03012620 Secured Access to Pembrolizumab for Patients With Selected Rare Cancer Types https://ClinicalTrials.gov/show/NCT03012620 Recruiting UNICANCER 2023-01-31
NCT02975882 Nanoparticle Albumin-Bound Rapamycin, Temozolomide, and Irinotecan Hydrochloride in Treating Pediatric Patients With Recurrent or Refractory Solid Tumors https://ClinicalTrials.gov/show/NCT02975882 Recruiting Children’s Oncology Group 2020-06-03
NCT03233204 Olaparib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With Defects in DNA Damage Repair Genes (A Pediatric MATCH Treatment Trial) https://ClinicalTrials.gov/show/NCT03233204 Recruiting National Cancer Institute (NCI) 2024-09-30
NCT02932280 Safety and Dose Finding Study of Neratinib in Children and Young Adults With Cancer That Has Returned or Not Responded to Treatment https://ClinicalTrials.gov/show/NCT02932280 Recruiting Memorial Sloan Kettering Cancer Center 2021-10-31
NCT03220035 Vemurafenib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With BRAF V600 Mutations (A Pediatric MATCH Treatment Trial) https://ClinicalTrials.gov/show/NCT03220035 Recruiting National Cancer Institute (NCI) 2023-12-31
NCT02808650 Prexasertib in Treating Pediatric Patients With Recurrent or Refractory Solid Tumors https://ClinicalTrials.gov/show/NCT02808650 Active, not recruiting Children’s Oncology Group 2019-12-31
NCT02797366 Proton Radiotherapy for Primary Central Nervous System Tumours in Adults https://ClinicalTrials.gov/show/NCT02797366 Recruiting Uppsala University 2020-07-31
NCT02793466 Durvalumab in Pediatric and Adolescent Patients https://ClinicalTrials.gov/show/NCT02793466 Recruiting Children’s Hospital Los Angeles 2019-12-31
NCT02780804 Entinostat in Treating Pediatric Patients With Recurrent or Refractory Solid Tumors https://ClinicalTrials.gov/show/NCT02780804 Active, not recruiting National Cancer Institute (NCI) 2022-04-30
NCT03213704 Larotrectinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With NTRK Fusions (A Pediatric MATCH Treatment Trial) https://ClinicalTrials.gov/show/NCT03213704 Recruiting National Cancer Institute (NCI) 2024-09-30
NCT02710240 Indocyanine Green for Central Nervous System Tumors https://ClinicalTrials.gov/show/NCT02710240 Active, not recruiting Abramson Cancer Center of the University of Pennsylvania 2020-09-30
NCT03213678 PI3K/mTOR Inhibitor LY3023414 in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With TSC or PI3K/MTOR Mutations (A Pediatric MATCH Treatment Trial) https://ClinicalTrials.gov/show/NCT03213678 Recruiting National Cancer Institute (NCI) 2024-09-30
NCT02687386 A Study of Intravenous EEDVsMit in Children With Recurrent / Refractory Solid or CNS Tumours Expressing EGFR https://ClinicalTrials.gov/show/NCT02687386 Recruiting Sydney Children’s Hospitals Network 2021-02-28
NCT02650401 Study Of Entrectinib (Rxdx-101) in Children and Adolescents With Locally Advanced Or Metastatic Solid Or Primary CNS Tumors And/Or Who Have No Satisfactory Treatment Options https://ClinicalTrials.gov/show/NCT02650401 Recruiting Hoffmann-La Roche 2023-06-01
NCT03213665 Tazemetostat in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With EZH2, SMARCB1, or SMARCA4 Gene Mutations (A Pediatric MATCH Treatment Trial) https://ClinicalTrials.gov/show/NCT03213665 Recruiting National Cancer Institute (NCI) 2024-09-30
NCT02574728 Sirolimus in Combination With Metronomic Chemotherapy in Children With Recurrent and/or Refractory Solid and CNS Tumors https://ClinicalTrials.gov/show/NCT02574728 Recruiting Emory University 2022-01-31
NCT03210714 Erdafitinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With FGFR Mutations (A Pediatric MATCH Treatment Trial) https://ClinicalTrials.gov/show/NCT03210714 Recruiting National Cancer Institute (NCI) 2024-12-31
NCT03155620 Targeted Therapy Directed by Genetic Testing in Treating Pediatric Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphomas, or Histiocytic Disorders (The Pediatric MATCH Screening Trial) https://ClinicalTrials.gov/show/NCT03155620 Recruiting National Cancer Institute (NCI) 2027-09-30
NCT03130959 An Investigational Immuno-therapy Study of Nivolumab Monotherapy and Nivolumab in Combination With Ipilimumab in Pediatric Patients With High Grade Primary CNS Malignancies https://ClinicalTrials.gov/show/NCT03130959 Active, not recruiting Bristol-Myers Squibb 2021-06-14
NCT00840047 Methionine PET/CT Studies In Patients With Cancer https://ClinicalTrials.gov/show/NCT00840047 Recruiting St. Jude Children’s Research Hospital 2027-07-27
NCT02496520 Dendritic Cell-based Immunotherapy for Advanced Solid Tumours of Children and Young Adults https://ClinicalTrials.gov/show/NCT02496520 Completed Clinica Universidad de Navarra, Universidad de Navarra 2018-09-16
NCT02462629 Study of BLZ-100 in Pediatric Subjects With CNS Tumors https://ClinicalTrials.gov/show/NCT02462629 Completed Blaze Bioscience Inc. 2018-07-31
NCT02451215 Laser Interstitial Thermal Therapy (LITT) for the Treatment of Pediatric Central Nervous System Tumors https://ClinicalTrials.gov/show/NCT02451215 Completed Children’s Hospitals and Clinics of Minnesota 2020-01-31
NCT02415153 Pomalidomide in Treating Younger Patients With Recurrent, Progressive, or Refractory Central Nervous System Tumors https://ClinicalTrials.gov/show/NCT02415153 Active, not recruiting National Cancer Institute (NCI) 2019-07-01
NCT02343081 Bioequivalence Study of Temozolomide in Patients With Primary Tumors of the Central Nervous System https://ClinicalTrials.gov/show/NCT02343081 Completed Monte Verde SA 2013-10-31
NCT02323880 Selinexor in Treating Younger Patients With Recurrent or Refractory Solid Tumors or High-Grade Gliomas https://ClinicalTrials.gov/show/NCT02323880 Recruiting Children’s Oncology Group 2021-03-31
NCT02164838 VEGF Receptor Tyrosine Kinase Inhibitor Axitinib in Children With Recurrent or Refractory Solid Tumors https://ClinicalTrials.gov/show/NCT02164838 Completed Children’s Oncology Group 2017-10-19
NCT02116777 Talazoparib and Temozolomide in Treating Younger Patients With Refractory or Recurrent Malignancies https://ClinicalTrials.gov/show/NCT02116777 Completed National Cancer Institute (NCI) 2018-12-31
NCT02100891 Phase 2 STIR Trial: Haploidentical Transplant and Donor Natural Killer Cells for Solid Tumors https://ClinicalTrials.gov/show/NCT02100891 Recruiting Medical College of Wisconsin 2020-12-31
NCT02095132 Adavosertib and Irinotecan Hydrochloride in Treating Younger Patients With Relapsed or Refractory Solid Tumors https://ClinicalTrials.gov/show/NCT02095132 Active, not recruiting National Cancer Institute (NCI) 2021-04-30
NCT01273090 Imetelstat Sodium in Treating Young Patients With Refractory or Recurrent Solid Tumors or Lymphoma https://ClinicalTrials.gov/show/NCT01273090 Completed Children’s Oncology Group 2013-09-30
NCT01941758 High-Dose Trivalent Influenza Vaccine in Inducing Immune Response Patients With Central Nervous System Tumors https://ClinicalTrials.gov/show/NCT01941758 Completed Wake Forest University Health Sciences 2014-11-30
NCT01931098 Oral Pazopanib Plus Oral Topotecan Metronomic Antiangiogenic Therapy for Recurrent Glioblastoma Multiforme (A) Without Prior Bevacizumab Exposure and (B) After Failing Prior Bevacizumab https://ClinicalTrials.gov/show/NCT01931098 Completed National Institutes of Health Clinical Center (CC) 2019-09-12
NCT01920191 Phase I/II Trial of IMA950 Multi-peptide Vaccine Plus Poly-ICLC in Glioblastoma https://ClinicalTrials.gov/show/NCT01920191 Completed University Hospital, Geneva 2016-03-31
NCT01709435 Cabozantinib S-Malate in Treating Younger Patients With Recurrent or Refractory Solid Tumors https://ClinicalTrials.gov/show/NCT01709435 Completed National Cancer Institute (NCI) 2018-12-31
NCT01538095 Trebananib in Treating Younger Patients With Relapsed or Refractory Solid Tumors, Including Central Nervous System Tumors https://ClinicalTrials.gov/show/NCT01538095 Completed National Cancer Institute (NCI) 2016-04-30
NCT01505569 Auto Transplant for High Risk or Relapsed Solid or CNS Tumors https://ClinicalTrials.gov/show/NCT01505569 Recruiting Masonic Cancer Center, University of Minnesota 2021-03-31
NCT01480050 Mibefradil Dihydrochloride and Temozolomide in Treating Patients With Recurrent Glioma https://ClinicalTrials.gov/show/NCT01480050 Completed Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 2015-08-31
NCT01390571 Olaparib and Temozolomide in Treating Patients With Relapsed Glioblastoma https://ClinicalTrials.gov/show/NCT01390571 Completed Cancer Research UK 2017-06-20
NCT01381718 Modafinil in Treating Children With Memory and Attention Problems Caused by Cancer Treatment for a Brain Tumor https://ClinicalTrials.gov/show/NCT01381718 Completed University of South Florida 2016-08-31
NCT01346267 Acupressure in Controlling Nausea in Young Patients Receiving Highly Emetogenic Chemotherapy https://ClinicalTrials.gov/show/NCT01346267 Completed University of South Florida 2016-05-31
NCT04217694 Memantine for the Reduction of Cognitive Impairment After Radiation Therapy in Pediatric Patients With Central Nervous System Tumors https://ClinicalTrials.gov/show/NCT04217694 Recruiting Mayo Clinic 2022-12-30
NCT04096716 Mapping Draining Lymph Nodes in CNS Malignancies https://ClinicalTrials.gov/show/NCT04096716 Recruiting Washington University School of Medicine 2020-12-31
NCT03990597 StrataXRT in Preventing Radiation Dermatitis in Pediatric Patients Undergoing Radiation Therapy to the Brain or Spinal Cord https://ClinicalTrials.gov/show/NCT03990597 Recruiting M.D. Anderson Cancer Center 2020-05-31
NCT03981016 Medical and Surgical Management of Patients With Brain Metastases https://ClinicalTrials.gov/show/NCT03981016 Active, not recruiting Institut du Cancer de Montpellier - Val d’Aurelle 2018-01-19
NCT03922555 ASTX727 in Recurrent/Progressive Non-enhancing IDH Mutant Gliomas https://ClinicalTrials.gov/show/NCT03922555 Recruiting Massachusetts General Hospital 2022-05-31
NCT03899792 A Study of Oral LOXO-292 in Pediatric Patients With Advanced Solid or Primary Central Nervous System Tumors https://ClinicalTrials.gov/show/NCT03899792 Recruiting Loxo Oncology, Inc. 2021-11-30
NCT03838042 INFORM2 Study Uses Nivolumab and Entinostat in Children and Adolescents With High-risk Refractory Malignancies https://ClinicalTrials.gov/show/NCT03838042 Recruiting University Hospital Heidelberg 2022-09-30
NCT03834961 Larotrectinib in Treating Patients With Previously Untreated TRK Fusion Solid Tumors and TRK Fusion Relapsed Acute Leukemia https://ClinicalTrials.gov/show/NCT03834961 Recruiting Children’s Oncology Group 2022-05-11
NCT03696355 Study of GDC-0084 in Pediatric Patients With Newly Diagnosed Diffuse Intrinsic Pontine Glioma or Diffuse Midline Gliomas https://ClinicalTrials.gov/show/NCT03696355 Active, not recruiting St. Jude Children’s Research Hospital 2021-01-31
NCT03690869 REGN2810 in Pediatric Patients With Relapsed, Refractory Solid, or Central Nervous System (CNS) Tumors and Safety and Efficacy of REGN2810 in Combination With Radiotherapy in Pediatric Patients With Newly Diagnosed or Recurrent Glioma https://ClinicalTrials.gov/show/NCT03690869 Recruiting Regeneron Pharmaceuticals 2025-01-27
NCT03638167 EGFR806-specific CAR T Cell Locoregional Immunotherapy for EGFR-positive Recurrent or Refractory Pediatric CNS Tumors https://ClinicalTrials.gov/show/NCT03638167 Recruiting Seattle Children’s Hospital 2022-03-31
NCT03598244 Volitinib in Treating Participants With Recurrent or Refractory Primary CNS Tumors https://ClinicalTrials.gov/show/NCT03598244 Recruiting National Cancer Institute (NCI) 2020-12-31
NCT03579602 Study of Tozuleristide and the Canvas Imaging System in Pediatric Subjects With CNS Tumors Undergoing Surgery https://ClinicalTrials.gov/show/NCT03579602 Recruiting Blaze Bioscience Inc. 2020-08-31
NCT03500991 HER2-specific CAR T Cell Locoregional Immunotherapy for HER2-positive Recurrent/Refractory Pediatric CNS Tumors https://ClinicalTrials.gov/show/NCT03500991 Recruiting Seattle Children’s Hospital 2021-07-26
NCT03496402 Biological Characterisation of High Risk CHildhood Cancer in Children, Adolescents and Young Adults (MICCHADO) https://ClinicalTrials.gov/show/NCT03496402 Recruiting Institut Curie 2025-04-01
NCT03434262 SJDAWN: St. Jude Children’s Research Hospital Phase 1 Study Evaluating Molecularly-Driven Doublet Therapies for Children and Young Adults With Recurrent Brain Tumors https://ClinicalTrials.gov/show/NCT03434262 Recruiting St. Jude Children’s Research Hospital 2025-02-28
NCT01222221 Vaccine Therapy, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme https://ClinicalTrials.gov/show/NCT01222221 Completed Cancer Research UK 2015-02-28
NCT01164189 Bevacizumab in Recurrent Grade II and III Glioma https://ClinicalTrials.gov/show/NCT01164189 Completed European Organisation for Research and Treatment of Cancer - EORTC 2017-01-19
NCT01158300 PTC299 in Treating Young Patients With Refractory or Recurrent Primary Central Nervous System Tumors https://ClinicalTrials.gov/show/NCT01158300 Completed Pediatric Brain Tumor Consortium 2015-01-31
NCT01135563 Study of Vinblastine and Sirolimus in Children With Recurrent/Refractory Solid Tumours Including CNS Tumours https://ClinicalTrials.gov/show/NCT01135563 Completed The Hospital for Sick Children 2012-04-30
NCT01062399 Everolimus, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme https://ClinicalTrials.gov/show/NCT01062399 Active, not recruiting Radiation Therapy Oncology Group 2016-06-30
NCT01026493 Veliparib and Temozolomide in Treating Patients With Recurrent Glioblastoma https://ClinicalTrials.gov/show/NCT01026493 Completed Radiation Therapy Oncology Group 2014-05-31
NCT01019434 Radiation Therapy and Temsirolimus or Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma https://ClinicalTrials.gov/show/NCT01019434 Completed European Organisation for Research and Treatment of Cancer - EORTC 2013-12-31
NCT00998010 Bortezomib, Temozolomide, and Regional Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma https://ClinicalTrials.gov/show/NCT00998010 Completed Jonsson Comprehensive Cancer Center 2018-04-19
NCT00990652 Presurgery Bortezomib for Recurrent Malignant Gliomas Followed by Postop Bortezomib & Temozolomide https://ClinicalTrials.gov/show/NCT00990652 Completed Northwestern University 2011-04-30
NCT00978458 Radiation Therapy With or Without Temozolomide in Treating Patients With Low-Grade Glioma https://ClinicalTrials.gov/show/NCT00978458 Active, not recruiting Eastern Cooperative Oncology Group 2021-12-31
NCT00974987 Boron Neutron Capture Therapy, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Multiforme https://ClinicalTrials.gov/show/NCT00974987 Completed Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan 2016-02-29
NCT00945828 Assessing the Effectiveness of Individual Education Plans for Childhood Cancer Survivors https://ClinicalTrials.gov/show/NCT00945828 Completed University of Miami 2010-10-31
NCT00935545 Study of Peptide Vaccination With Tumor Associated Antigens Mixed With Montanide in Patients With CNS Tumors https://ClinicalTrials.gov/show/NCT00935545 Completed NYU Langone Health 2014-01-31
NCT00935090 3’-Deoxy-3’-[18F] Fluorothymidine PET Imaging in Patients With Cancer https://ClinicalTrials.gov/show/NCT00935090 Recruiting Barbara Ann Karmanos Cancer Institute 2021-04-30
NCT00905060 HSPPC-96 Vaccine With Temozolomide in Patients With Newly Diagnosed GBM https://ClinicalTrials.gov/show/NCT00905060 Completed University of California, San Francisco 2014-04-30
NCT00895622 Observation or Radiation Therapy in Treating Patients With Grade I, Grade II, or Grade III Meningioma https://ClinicalTrials.gov/show/NCT00895622 Active, not recruiting Radiation Therapy Oncology Group 2016-09-30
NCT00890032 Vaccine Therapy in Treating Patients Undergoing Surgery for Recurrent Glioblastoma Multiforme https://ClinicalTrials.gov/show/NCT00890032 Completed Duke University 2014-10-31
NCT00887146 Radiation Therapy With Concomitant and Adjuvant Temozolomide Versus Radiation Therapy With Adjuvant PCV Chemotherapy in Patients With Anaplastic Glioma or Low Grade Glioma https://ClinicalTrials.gov/show/NCT00887146 Recruiting Alliance for Clinical Trials in Oncology 2025-10-31
NCT00876993 Study of Irinotecan and Bevacizumab With Temozolomide in Refractory/Relapsed Central Nervous System (CNS) Tumors https://ClinicalTrials.gov/show/NCT00876993 Completed Johns Hopkins All Children’s Hospital 2015-09-30
NCT00869401 Dasatinib or Placebo, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Multiforme https://ClinicalTrials.gov/show/NCT00869401 Completed Alliance for Clinical Trials in Oncology 2014-10-31
NCT00867178 Vorinostat Combined With Isotretinoin and Chemotherapy in Treating Younger Patients With Embryonal Tumors of the Central Nervous System https://ClinicalTrials.gov/show/NCT00867178 Active, not recruiting National Cancer Institute (NCI) 2018-12-30
NCT00832598 [18F] FACBC and [18F] FLT PET Imaging in Central Nervous System Tumors https://ClinicalTrials.gov/show/NCT00832598 Completed Memorial Sloan Kettering Cancer Center 2017-03-21
NCT00823524 Donor Natural Killer Cells After Donor Stem Cell Transplant in Treating Patients With Advanced Cancer https://ClinicalTrials.gov/show/NCT00823524 Completed Asan Medical Center 2013-02-28
NCT04276194 Vertebral Body Sparing Craniospinal Irradiation for Pediatric Patients With Cancer of the Central Nervous System https://ClinicalTrials.gov/show/NCT04276194 Recruiting Emory University 2021-12-31
NCT04185038 Study of B7-H3-Specific CAR T Cell Locoregional Immunotherapy for Diffuse Intrinsic Pontine Glioma/Diffuse Midline Glioma and Recurrent or Refractory Pediatric Central Nervous System Tumors https://ClinicalTrials.gov/show/NCT04185038 Recruiting Seattle Children’s Hospital 2026-05-31
NCT03911388 HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors https://ClinicalTrials.gov/show/NCT03911388 Recruiting University of Alabama at Birmingham 2023-09-01
NCT02867592 Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors https://ClinicalTrials.gov/show/NCT02867592 Recruiting National Cancer Institute (NCI) 2020-09-30
NCT03257631 A Study of Pomalidomide Monotherapy for Children and Young Adults With Recurrent or Progressive Primary Brain Tumors https://ClinicalTrials.gov/show/NCT03257631 Active, not recruiting Celgene 2018-11-23
NCT03965494 AXL Inhibitor BGB324 in Treating Participants With Recurrent Glioblastoma Undergoing Surgery https://ClinicalTrials.gov/show/NCT03965494 Recruiting Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 2022-12-01
NCT00788125 Dasatinib, Ifosfamide, Carboplatin, and Etoposide in Treating Young Patients With Metastatic or Recurrent Malignant Solid Tumors https://ClinicalTrials.gov/show/NCT00788125 Active, not recruiting City of Hope Medical Center 2023-09-30
NCT00784914 A Feasibility, Dose-Escalation Study Using Intracerebral Microdialysis to Assess the Neuropharmacodynamics of Temsirolimus in Patients With Primary or Metastatic Brain Tumors https://ClinicalTrials.gov/show/NCT00784914 Completed City of Hope Medical Center 2010-11-30
NCT00770471 ABT-888, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Multiforme https://ClinicalTrials.gov/show/NCT00770471 Completed Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 2012-03-01
NCT00756340 A Trial of Everolimus and Bevacizumab in Children With Recurrent Solid Tumors https://ClinicalTrials.gov/show/NCT00756340 Completed St. Jude Children’s Research Hospital 2015-09-30
NCT00752323 Imaging Procedure Using ALA in Finding Residual Tumor in Grade IV Malignant Astrocytoma https://ClinicalTrials.gov/show/NCT00752323 Completed Case Comprehensive Cancer Center 2018-09-15
NCT00750009 Personalized Information or Basic Information in Helping Patients Make Decisions About Participating in a Clinical Trial https://ClinicalTrials.gov/show/NCT00750009 Completed Case Comprehensive Cancer Center 2012-12-31
NCT00730613 Cellular Adoptive Immunotherapy Using Genetically Modified T-Lymphocytes in Treating Patients With Recurrent or Refractory High-Grade Malignant Glioma https://ClinicalTrials.gov/show/NCT00730613 Completed City of Hope Medical Center 2011-08-31
NCT00720564 Radiation Therapy, Arsenic Trioxide, and Temozolomide in Treating Patients With Newly Diagnosed High-Grade Glioma https://ClinicalTrials.gov/show/NCT00720564 Completed City of Hope Medical Center 2009-02-28
NCT00720356 Bevacizumab and Erlotinib After Radiation Therapy and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma https://ClinicalTrials.gov/show/NCT00720356 Completed Northwestern University 2014-06-24
NCT00716976 Sodium Thiosulfate in Preventing Hearing Loss in Young Patients Receiving Cisplatin for Newly Diagnosed Germ Cell Tumor, Hepatoblastoma, Medulloblastoma, Neuroblastoma, Osteosarcoma, or Other Malignancy https://ClinicalTrials.gov/show/NCT00716976 Completed Children’s Oncology Group 2015-04-30
NCT00666211 Opioid Titration Order Sheet or Standard Care in Treating Patients With Cancer Pain https://ClinicalTrials.gov/show/NCT00666211 Completed Vanderbilt-Ingram Cancer Center 2010-01-31
NCT00820963 Standard Radiation Therapy, Higher-Dose Radiation Therapy, or Chemotherapy in Treating Older Patients With Glioblastoma Multiforme https://ClinicalTrials.gov/show/NCT00820963 Completed National Cancer Institute (NCI) 2011-05-31
NCT00629889 Levetiracetam or Pregabalin in Treating Seizures in Patients Undergoing Chemotherapy and/or Radiation Therapy For Primary Brain Tumors https://ClinicalTrials.gov/show/NCT00629889 Completed Centre Hospitalier Universitaire Vaudois 2012-05-31
NCT00626990 Phase III Trial of Anaplastic Glioma Without 1p/19q LOH https://ClinicalTrials.gov/show/NCT00626990 Active, not recruiting European Organisation for Research and Treatment of Cancer - EORTC 2022-01-31
NCT00626730 Radiation Therapy in Treating Patients Who Have Undergone Surgery for Newly Diagnosed Grade II or Grade III Meningioma https://ClinicalTrials.gov/show/NCT00626730 Completed European Organisation for Research and Treatment of Cancer - EORTC 2013-02-28
NCT00621686 Bevacizumab and Sorafenib in Treating Patients With Recurrent Glioblastoma Multiforme https://ClinicalTrials.gov/show/NCT00621686 Completed Alliance for Clinical Trials in Oncology 2010-10-31
NCT00619112 Temozolomide in Treating Patients With Recurrent High-Grade Glioma https://ClinicalTrials.gov/show/NCT00619112 Completed University of California, San Francisco 2011-12-31
NCT00612001 Vaccine Therapy in Treating Patients With Malignant Glioma https://ClinicalTrials.gov/show/NCT00612001 Completed Jonsson Comprehensive Cancer Center 2011-01-31
NCT00602667 Risk-Adapted Therapy for Young Children With Embryonal Brain Tumors, Choroid Plexus Carcinoma, High Grade Glioma or Ependymoma https://ClinicalTrials.gov/show/NCT00602667 Active, not recruiting St. Jude Children’s Research Hospital 2017-09-27
NCT00589784 Phase II Trial of Sunitinib (SU011248) in Patients With Recurrent or Inoperable Meningioma https://ClinicalTrials.gov/show/NCT00589784 Completed Memorial Sloan Kettering Cancer Center 2014-10-31
NCT00553150 Everolimus, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma https://ClinicalTrials.gov/show/NCT00553150 Completed Alliance for Clinical Trials in Oncology 2012-01-31
NCT00547131 Temozolomide in Treating Patients With Primary Brain Tumors or Metastatic Brain Tumors https://ClinicalTrials.gov/show/NCT00547131 Completed City of Hope Medical Center 2008-05-31
NCT00544284 Bortezomib and Temozolomide in Treating Patients With Brain Tumors or Other Solid Tumors That Have Not Responded to Treatment https://ClinicalTrials.gov/show/NCT00544284 Completed City of Hope Medical Center 2012-01-31
NCT00541138 Tamoxifen, Carboplatin, and Topotecan in Treating Patients With CNS Metastases or Recurrent Brain or Spinal Cord Tumors https://ClinicalTrials.gov/show/NCT00541138 Completed City of Hope Medical Center 2007-10-31
NCT00521183 Cytochlor, Tetrahydrouridine, and External-Beam Radiation Therapy in Treating Patients With Cancer That Has Spread to the Brain https://ClinicalTrials.gov/show/NCT00521183 Completed University of Miami 2014-05-31
NCT00513981 High-Dose Methotrexate in Treating Young Patients With Solid Tumors https://ClinicalTrials.gov/show/NCT00513981 Completed National Cancer Institute (NCI) 2008-03-31
NCT00509431 Erlotinib and Sirolimus in Treating Patients With Recurrent Malignant Glioma https://ClinicalTrials.gov/show/NCT00509431 Completed Jonsson Comprehensive Cancer Center 2011-12-31
NCT00503724 Enzastaurin in Treating Young Patients With Refractory Primary CNS Tumors https://ClinicalTrials.gov/show/NCT00503724 Completed Pediatric Brain Tumor Consortium 2010-05-31
NCT00498927 Temozolomide in Treating Patients With Recurrent Glioblastoma Multiforme or Other Malignant Glioma https://ClinicalTrials.gov/show/NCT00498927 Completed Memorial Sloan Kettering Cancer Center 2013-12-31
NCT00486603 Hydroxychloroquine, Radiation, and Temozolomide Treating Patients With Newly Diagnosed Glioblastoma Multiforme https://ClinicalTrials.gov/show/NCT00486603 Completed Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 2013-06-30
NCT00482677 Radiation Therapy With or Without Temozolomide in Treating Older Patients With Newly Diagnosed Glioblastoma Multiforme https://ClinicalTrials.gov/show/NCT00482677 Completed Canadian Cancer Trials Group 2016-03-01
NCT00472017 Vandetanib and Radiation Therapy in Treating Young Patients With Newly Diagnosed Diffuse Brainstem Glioma https://ClinicalTrials.gov/show/NCT00472017 Completed St. Jude Children’s Research Hospital 2011-10-31
NCT00470366 Combination Chemotherapy and Pegfilgrastim in Treating Patients With Previously Untreated Germ Cell Tumors https://ClinicalTrials.gov/show/NCT00470366 Completed Memorial Sloan Kettering Cancer Center 2016-06-30
NCT00463008 Pharmacologic Study of Methotrexate in Patients Undergoing Stereotactic Biopsy for Recurrent High-Grade Glioma https://ClinicalTrials.gov/show/NCT00463008 Completed National Cancer Institute (NCI) NA
NCT00452868 Donepezil in Treating Young Patients With Primary Brain Tumors Previously Treated With Radiation Therapy to the Brain https://ClinicalTrials.gov/show/NCT00452868 Completed Wake Forest University Health Sciences 2010-02-28
NCT00445965 Iodine I 131 Monoclonal Antibody 3F8 in Treating Patients With Central Nervous System Cancer or Leptomeningeal Cancer https://ClinicalTrials.gov/show/NCT00445965 Active, not recruiting Memorial Sloan Kettering Cancer Center 2021-01-31
NCT00424242 Pemetrexed Disodium in the Cerebrospinal Fluid of Patients With Leptomeningeal Metastases https://ClinicalTrials.gov/show/NCT00424242 Active, not recruiting Northwestern University 2020-03-31
NCT00424060 Epothilone ZK-219477 in Treating Patients With Recurrent Glioblastoma https://ClinicalTrials.gov/show/NCT00424060 Completed European Organisation for Research and Treatment of Cancer - EORTC 2007-08-31
NCT00423852 Paclitaxel, Ifosfamide, and Carboplatin Followed By Autologous Stem Cell Transplant in Treating Patients With Germ Cell Tumors That Did Not Respond to Cisplatin https://ClinicalTrials.gov/show/NCT00423852 Completed Memorial Sloan Kettering Cancer Center 2013-02-28
NCT00416923 Intrathecal Rituximab in Treating Patients With Recurrent CNS Lymphoma https://ClinicalTrials.gov/show/NCT00416923 Completed University of California, San Francisco 2005-11-30
NCT00416819 Combination Chemotherapy and Rituximab in Treating Patients With Newly Diagnosed Primary CNS Lymphoma https://ClinicalTrials.gov/show/NCT00416819 Completed University of California, San Francisco 2005-12-31
NCT00407433 Clinical Studies of Gemcitabine-Oxaliplatin https://ClinicalTrials.gov/show/NCT00407433 Completed Gustave Roussy, Cancer Campus, Grand Paris NA
NCT00404248 Tetra-O-Methyl Nordihydroguaiaretic Acid in Treating Patients With Recurrent High-Grade Glioma https://ClinicalTrials.gov/show/NCT00404248 Completed Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 2009-06-30
NCT00401024 Tumor Tissue Analysis in Patients Receiving Imatinib Mesylate for Malignant Glioma https://ClinicalTrials.gov/show/NCT00401024 Completed Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 2008-02-04
NCT00400816 Temozolomide in Treating Patients With Newly Diagnosed Anaplastic Oligodendroglioma or Mixed Oligoastrocytoma https://ClinicalTrials.gov/show/NCT00400816 Completed The Cleveland Clinic 2008-01-17
NCT00390403 Gossypol (AT-101) and Temozolomide With or Without Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme https://ClinicalTrials.gov/show/NCT00390403 Completed Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 2009-06-30
NCT00389584 Irinotecan and Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases From Solid Tumors https://ClinicalTrials.gov/show/NCT00389584 Completed University of California, Davis 2006-11-30
NCT00387933 Imatinib Mesylate, Vatalanib, and Hydroxyurea in Treating Patients With Recurrent or Relapsed Malignant Glioma https://ClinicalTrials.gov/show/NCT00387933 Completed Duke University 2009-01-31
NCT00387400 Temozolomide + Everolimus in Newly Diagnosed, Recurrent, or Progressive Malignant Glioblastoma Multiforme https://ClinicalTrials.gov/show/NCT00387400 Completed Canadian Cancer Trials Group 2010-09-24
NCT00376818 Stress Reduction Program in Patients With Malignant Brain Tumors and Their Family Caregivers https://ClinicalTrials.gov/show/NCT00376818 Completed Case Comprehensive Cancer Center 2008-04-30
NCT00357500 Etoposide, Cyclophosphamide, Thalidomide, Celecoxib, and Fenofibrate in Relapsed or Progressive Cancer https://ClinicalTrials.gov/show/NCT00357500 Completed Dana-Farber Cancer Institute 2013-02-28
NCT00357253 Capecitabine and Radiation Therapy in Treating Young Patients With Newly Diagnosed, Nonmetastatic Brain Stem Glioma or High-Grade Glioma https://ClinicalTrials.gov/show/NCT00357253 Completed Pediatric Brain Tumor Consortium 2010-03-31
NCT00354068 Imatinib Mesylate and Temozolomide in Treating Patients With Malignant Glioma https://ClinicalTrials.gov/show/NCT00354068 Completed Duke University 2008-11-30
NCT00352521 Dynamic Contrast-Enhanced Magnetic Resonance Imaging (DCE-MRI) With Bevacizumab and Irinotecan for Malignant Glioma https://ClinicalTrials.gov/show/NCT00352521 Completed Duke University 2006-12-31
NCT00352495 Vinblastine and Carboplatin in Treating Young Patients With Newly Diagnosed or Recurrent Low-Grade Glioma https://ClinicalTrials.gov/show/NCT00352495 Completed Children’s Oncology Group 2011-09-30
NCT00352313 ATN-161 and Carboplatin in Treating Patients With Recurrent Malignant Glioma https://ClinicalTrials.gov/show/NCT00352313 Completed National Institutes of Health Clinical Center (CC) 2007-01-31
NCT00348790 Vatalanib in Treating Patients With Recurrent or Progressive Meningioma https://ClinicalTrials.gov/show/NCT00348790 Completed Northwestern University 2010-11-30
NCT00337207 Bevacizumab in Treating Patients With Recurrent or Progressive Glioma https://ClinicalTrials.gov/show/NCT00337207 Completed Northwestern University 2008-11-30
NCT00331526 Cellular Adoptive Immunotherapy in Treating Patients With Glioblastoma Multiforme https://ClinicalTrials.gov/show/NCT00331526 Completed Hoag Memorial Hospital Presbyterian 2008-12-31
NCT00329589 A Trial Using Velcade Plus Chemoradiation for Central Nervous System, Head and Neck, and Cervical Cancer Patients https://ClinicalTrials.gov/show/NCT00329589 Completed Thomas Jefferson University 2010-06-30
NCT00328458 EPO906 Plus Radiation Therapy for the Treatment of Cancer Patients https://ClinicalTrials.gov/show/NCT00328458 Completed Thomas Jefferson University 2008-05-31
NCT00313729 Temozolomide in Treating Patients With Low-Grade Glioma https://ClinicalTrials.gov/show/NCT00313729 Completed University of California, San Francisco 2014-09-25
NCT00313599 Lapatinib and Paclitaxel in Treating Patients With Advanced Solid Tumors https://ClinicalTrials.gov/show/NCT00313599 Completed University of California, San Francisco 2013-12-31
NCT00304031 Radiation Therapy (RT) and Temozolomide (TMZ) in Treating Patients With Newly Diagnosed Glioblastoma or Gliosarcoma https://ClinicalTrials.gov/show/NCT00304031 Completed Radiation Therapy Oncology Group 2011-02-28
NCT00303940 Talabostat Combined With Temozolomide or Carboplatin in Treating Young Patients With Relapsed or Refractory Brain Tumors or Other Solid Tumors https://ClinicalTrials.gov/show/NCT00303940 Completed National Institutes of Health Clinical Center (CC) NA
NCT00303810 Radiation Therapy and Combination Chemotherapy in Treating Young Patients With Medulloblastoma, Supratentorial Primitive Neuroectodermal Tumor, or Ependymoma https://ClinicalTrials.gov/show/NCT00303810 Completed Universitätsklinikum Hamburg-Eppendorf 2013-12-31
NCT00293423 GP96 Heat Shock Protein-Peptide Complex Vaccine in Treating Patients With Recurrent or Progressive Glioma https://ClinicalTrials.gov/show/NCT00293423 Completed University of California, San Francisco 2013-08-31
NCT00293358 Combination Chemotherapy and Radiation Therapy in Treating Patients With Germ Cell Tumors in the Brain https://ClinicalTrials.gov/show/NCT00293358 Completed National Cancer Institute (NCI) NA
NCT00276783 Pemetrexed Disodium in Treating Patients With Recurrent Malignant Gliomas, Primary CNS Lymphoma, or Brain Metastases https://ClinicalTrials.gov/show/NCT00276783 Active, not recruiting Northwestern University 2022-12-31
NCT00276770 Positron Emission Tomography Using Fluorothymidine F 18 in Finding Recurrent Disease in Patients With Gliomas https://ClinicalTrials.gov/show/NCT00276770 Completed University of Washington 2007-05-31
NCT00276640 Radiation Therapy or Combination Chemotherapy in Treating Patients With Clinically or Radiologically Progressive Low-Grade Gliomas https://ClinicalTrials.gov/show/NCT00276640 Completed Societe Internationale d’Oncologie Pediatrique 2015-12-31
NCT00275067 Arsenic Trioxide, Temozolomide, and Radiation Therapy in Treating Patients With Malignant Glioma That Has Been Removed By Surgery https://ClinicalTrials.gov/show/NCT00275067 Active, not recruiting Northwestern University 2021-05-31
NCT00275002 O6-Benzylguanine and Temozolomide in Treating Young Patients With Recurrent or Progressive Gliomas or Brain Stem Tumors https://ClinicalTrials.gov/show/NCT00275002 Completed National Cancer Institute (NCI) 2010-07-31
NCT00274833 Radiation Therapy, Temozolomide, and Erlotinib in Treating Patients With Newly Diagnosed Glioblastoma Multiforme https://ClinicalTrials.gov/show/NCT00274833 Completed Case Comprehensive Cancer Center 2007-10-31
NCT00274755 Magnetic Resonance Imaging and Magnetic Resonance Spectroscopic Imaging in Evaluating Patients Who Are Undergoing Treatment for Gliomas https://ClinicalTrials.gov/show/NCT00274755 Completed University of California, San Francisco 2007-04-30
NCT00268359 Bevacizumab and Irinotecan in Treating Patients With Recurrent or Refractory Gliomas https://ClinicalTrials.gov/show/NCT00268359 Completed Duke University 2006-08-31
NCT00258453 Observation of Young Patients Who Are Undergoing Surgery for Craniopharyngioma https://ClinicalTrials.gov/show/NCT00258453 Completed National Cancer Institute (NCI) 2007-09-30
NCT00253487 Combination Chemotherapy and Radiation Therapy in Treating Younger Patients Who Are Undergoing an Autologous Stem Cell Transplant for Newly Diagnosed Gliomas https://ClinicalTrials.gov/show/NCT00253487 Completed National Cancer Institute (NCI) 2012-08-31
NCT00253448 Stereotactic Radiosurgery and Radiation Therapy in Treating Patients With Glioblastoma Multiforme https://ClinicalTrials.gov/show/NCT00253448 Completed Case Comprehensive Cancer Center 2009-12-31
NCT00251797 A Phase I Trial Using Combination Irinotecan and Thalidomide for Recurrent CNS Tumors https://ClinicalTrials.gov/show/NCT00251797 Completed University of New Mexico 2006-06-30
NCT00238264 Radiation Therapy in Treating Young Patients With Gliomas https://ClinicalTrials.gov/show/NCT00238264 Completed Children’s Oncology Group 2013-12-30
NCT00187226 A Study for Image-Guided Radiation Therapy in Pediatric Brain Tumors and Side Effects https://ClinicalTrials.gov/show/NCT00187226 Active, not recruiting St. Jude Children’s Research Hospital 2005-03-31
NCT00185848 Assessing the Suitability of an Imaging Probe for Use in Clinical Cell and Gene Therapy Trials in Cancer and Rheumatoid Arthritis https://ClinicalTrials.gov/show/NCT00185848 Completed Stanford University 2013-06-30
NCT00182819 Radiation Therapy or Temozolomide in Treating Patients With Gliomas https://ClinicalTrials.gov/show/NCT00182819 Completed European Organisation for Research and Treatment of Cancer - EORTC 2013-08-31
NCT00152126 Chemotherapy With CD133+ Select Autologous Hematopoietic Stem Cells for Children With Solid Tumors and Lymphomas https://ClinicalTrials.gov/show/NCT00152126 Completed St. Jude Children’s Research Hospital 2005-08-31
NCT00138216 Temozolomide, Vincristine, and Irinotecan in Treating Young Patients With Refractory Solid Tumors https://ClinicalTrials.gov/show/NCT00138216 Completed Children’s Oncology Group 2009-06-30
NCT00128700 Temozolomide and Radiation Therapy With or Without Vatalanib in Treating Patients With Newly Diagnosed Glioblastoma Multiforme https://ClinicalTrials.gov/show/NCT00128700 Completed European Organisation for Research and Treatment of Cancer - EORTC 2007-11-30
NCT00128635 Iodine I 131 Monoclonal Antibody TNT-1/B in Treating Patients With Progressive or Recurrent Glioblastoma Multiforme https://ClinicalTrials.gov/show/NCT00128635 Completed Abramson Cancer Center of the University of Pennsylvania NA
NCT00124657 Erlotinib and Radiation Therapy in Treating Young Patients With Newly Diagnosed Glioma https://ClinicalTrials.gov/show/NCT00124657 Completed St. Jude Children’s Research Hospital 2012-07-31
NCT00118222 High Light and Low Light Dose PDT in Glioma https://ClinicalTrials.gov/show/NCT00118222 Completed Case Comprehensive Cancer Center 2006-03-31
NCT00114140 Temozolomide and Radiation Therapy in Treating Patients With Gliomas https://ClinicalTrials.gov/show/NCT00114140 Active, not recruiting Radiation Therapy Oncology Group 2013-02-28
NCT00112502 Temozolomide Alone or in Combination With Thalidomide and/or Isotretinoin and/or Celecoxib in Treating Patients Who Have Undergone Radiation Therapy for Glioblastoma Multiforme https://ClinicalTrials.gov/show/NCT00112502 Completed M.D. Anderson Cancer Center 2014-09-30
NCT00107458 Valproic Acid in Treating Young Patients With Recurrent or Refractory Solid Tumors or CNS Tumors https://ClinicalTrials.gov/show/NCT00107458 Completed Children’s Oncology Group 2007-10-31
NCT00107237 AEE788 and Everolimus in Treating Patients With Recurrent or Relapsed Glioblastoma Multiforme https://ClinicalTrials.gov/show/NCT00107237 Completed Novartis 2006-06-30
NCT00107185 Vaccine Therapy in Treating Young Patients Who Are Undergoing Surgery for Malignant Glioma https://ClinicalTrials.gov/show/NCT00107185 Completed Jonsson Comprehensive Cancer Center 2009-10-31
NCT00105560 Proton Beam Radiation Therapy in Treating Young Patients Who Have Undergone Biopsy or Surgery for Medulloblastoma or Pineoblastoma https://ClinicalTrials.gov/show/NCT00105560 Active, not recruiting Massachusetts General Hospital 2012-12-31
NCT00100802 Radiation Therapy, Temozolomide, and Lomustine in Treating Young Patients With Newly Diagnosed Gliomas https://ClinicalTrials.gov/show/NCT00100802 Completed Children’s Oncology Group 2012-09-01
NCT00099125 Radiation Therapy, Temozolomide, and Irinotecan in Treating Patients With Newly Diagnosed Glioblastoma Multiforme https://ClinicalTrials.gov/show/NCT00099125 Completed Radiation Therapy Oncology Group 2006-10-31
NCT00099060 Lapatinib in Treating Patients With Recurrent Glioblastoma Multiforme https://ClinicalTrials.gov/show/NCT00099060 Completed National Cancer Institute (NCI) 2007-11-30
NCT00098865 Thalidomide and Temozolomide in Relapsed or Progressive CNS Disease or Neuroblastoma https://ClinicalTrials.gov/show/NCT00098865 Completed Dana-Farber Cancer Institute 2010-06-30
NCT00095771 Arsenic Trioxide and Radiation Therapy in Treating Young Patients With Newly Diagnosed Gliomas https://ClinicalTrials.gov/show/NCT00095771 Completed Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 2011-01-31
NCT00002543 Gallium Nitrate in Treating Children With Brain Tumor, Neuroblastoma, Rhabdomyosarcoma, Non-Hodgkin’s Lymphoma, or Refractory Solid Tumors https://ClinicalTrials.gov/show/NCT00002543 Completed National Cancer Institute (NCI) NA
NCT00003775 Leflunomide in Treating Patients With Anaplastic Astrocytoma in First Relapse https://ClinicalTrials.gov/show/NCT00003775 Completed Pfizer 2006-05-31
NCT00003625 Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Newly Diagnosed Brain Stem Glioma https://ClinicalTrials.gov/show/NCT00003625 Completed Children’s Oncology Group 2001-02-28
NCT00003241 Phenylacetate in Treating Children With Recurrent or Progressive Brain Tumors https://ClinicalTrials.gov/show/NCT00003241 Completed National Cancer Institute (NCI) NA
NCT00003134 Irinotecan in Treating Patients With Recurrent Glioma https://ClinicalTrials.gov/show/NCT00003134 Completed Alliance for Clinical Trials in Oncology 2001-10-31
NCT00003304 Temozolomide in Treating Patients With Recurrent Oligodendroglial Tumors https://ClinicalTrials.gov/show/NCT00003304 Completed European Organisation for Research and Treatment of Cancer - EORTC 2000-03-31
NCT00003751 Penicillamine, Low Copper Diet, and Radiation Therapy in Treating Patients With Glioblastoma https://ClinicalTrials.gov/show/NCT00003751 Completed Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 2004-06-30
NCT00003348 Carmustine Plus O(6)-Benzylguanine in Treating Patients With Recurrent or Progressive Gliomas of the Brain https://ClinicalTrials.gov/show/NCT00003348 Completed Duke University 2000-08-31
NCT00002749 Carboplatin in Patients With Progressive Gliomas https://ClinicalTrials.gov/show/NCT00002749 Completed Duke University NA
NCT00002619 Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Glioblastoma Multiforme or Brain Stem Tumors https://ClinicalTrials.gov/show/NCT00002619 Completed NYU Langone Health 2000-04-30
NCT00004937 Acridine Carboxamide in Treating Patients With Recurrent Glioblastoma Multiforme https://ClinicalTrials.gov/show/NCT00004937 Completed European Organisation for Research and Treatment of Cancer - EORTC 2000-05-31
NCT00089245 Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Refractory, Recurrent, or Advanced CNS or Leptomeningeal Cancer https://ClinicalTrials.gov/show/NCT00089245 Active, not recruiting Y-mAbs Therapeutics 2019-07-01
NCT00004080 Gene Therapy in Treating Patients With Recurrent or Progressive Brain Tumors https://ClinicalTrials.gov/show/NCT00004080 Completed National Cancer Institute (NCI) NA
NCT00002824 Gene Therapy in Treating Patients With Primary Brain Tumors https://ClinicalTrials.gov/show/NCT00002824 Completed Abramson Cancer Center of the University of Pennsylvania NA
NCT00002754 Monoclonal Antibody Therapy in Treating Patients With Primary or Metastatic Melanoma or Brain Tumors https://ClinicalTrials.gov/show/NCT00002754 Completed Duke University 2001-04-30
NCT00002753 Monoclonal Antibody Therapy in Treating Patients With Recurrent Gliomas https://ClinicalTrials.gov/show/NCT00002753 Completed Duke University 2001-04-30
NCT00002572 Cytotoxic T Cells and Interleukin-2 in Treating Adult Patients With Recurrent Brain Tumors https://ClinicalTrials.gov/show/NCT00002572 Completed University of Colorado, Denver 1999-12-31
NCT00004041 Gene Therapy in Treating Patients With Recurrent Malignant Gliomas https://ClinicalTrials.gov/show/NCT00004041 Completed Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 2002-07-22
NCT00002620 Radiation Therapy in Treating Patients With Brain Cancer https://ClinicalTrials.gov/show/NCT00002620 Completed European Organisation for Research and Treatment of Cancer - EORTC 2000-06-30
NCT00002545 Radiation Therapy Plus Chemotherapy in Treating Patients With Supratentorial Glioblastoma Multiforme https://ClinicalTrials.gov/show/NCT00002545 Completed Radiation Therapy Oncology Group 2004-12-31
NCT00087061 Gimatecan in Treating Patients With Recurrent or Progressive Primary Malignant Glioma https://ClinicalTrials.gov/show/NCT00087061 Completed National Cancer Institute (NCI) NA
NCT00086879 Erlotinib Compared With Temozolomide or Carmustine in Treating Patients With Recurrent Glioblastoma Multiforme https://ClinicalTrials.gov/show/NCT00086879 Completed European Organisation for Research and Treatment of Cancer - EORTC 2006-03-31
NCT00005826 Nitrocamptothecin in Treating Patients With Glioblastoma Multiforme https://ClinicalTrials.gov/show/NCT00005826 Completed European Organisation for Research and Treatment of Cancer - EORTC 2000-09-30
NCT00003996 Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme https://ClinicalTrials.gov/show/NCT00003996 Completed Alliance for Clinical Trials in Oncology 2001-08-31
NCT00003574 Radiation Therapy in Treating Patients With Progressive or Recurrent Malignant Brain Tumors https://ClinicalTrials.gov/show/NCT00003574 Completed National Cancer Institute (NCI) NA
NCT00085566 Everolimus and Gefitinib in Treating Patients With Progressive Glioblastoma Multiforme or Progressive Metastatic Prostate Cancer https://ClinicalTrials.gov/show/NCT00085566 Completed Memorial Sloan Kettering Cancer Center 2008-02-29
NCT00085202 Treatment of Patients With Newly Diagnosed Medulloblastoma, Supratentorial Primitive Neuroectodermal Tumor, or Atypical Teratoid Rhabdoid Tumor https://ClinicalTrials.gov/show/NCT00085202 Active, not recruiting St. Jude Children’s Research Hospital 2016-12-31
NCT00085098 Radiation Therapy Compared With Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Primary Central Nervous System (CNS) Germ Cell Tumor https://ClinicalTrials.gov/show/NCT00085098 Completed Children’s Oncology Group 2009-05-31
NCT00084838 Chemotherapy Combined With Radiation Therapy for Newly Diagnosed CNS AT/RT https://ClinicalTrials.gov/show/NCT00084838 Completed Dana-Farber Cancer Institute 2008-02-29
NCT00003859 Surgery Plus Radiation Therapy With or Without Chemotherapy in Treating Children With Primitive Neuroectodermal Tumors of the CNS https://ClinicalTrials.gov/show/NCT00003859 Completed National Cancer Institute (NCI) NA
NCT00003410 Motexafin Gadolinium With MRI-Guided Surgery in Treating Patients With High-Grade Gliomas https://ClinicalTrials.gov/show/NCT00003410 Completed National Cancer Institute (NCI) NA
NCT00003372 Topotecan in Treating Patients With Recurrent Brain Tumors https://ClinicalTrials.gov/show/NCT00003372 Completed Canadian Cancer Trials Group 2000-10-05
NCT00003939 Ecteinascidin 743 in Treating Patients With Advanced Soft Tissue Sarcoma https://ClinicalTrials.gov/show/NCT00003939 Completed European Organisation for Research and Treatment of Cancer - EORTC 2000-11-30
NCT00003293 SU-101 Compared With Procarbazine in Treating Patients With Glioblastoma Multiforme https://ClinicalTrials.gov/show/NCT00003293 Completed Pfizer 2001-05-31
NCT00006358 Temozolomide Plus Thalidomide in Treating Patients With Recurrent or Progressive Brain Tumor https://ClinicalTrials.gov/show/NCT00006358 Completed Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 2003-01-23
NCT00002806 Chemotherapy Followed by Radiation Therapy in Treating Adults With Supratentorial Glioma https://ClinicalTrials.gov/show/NCT00002806 Completed Alliance for Clinical Trials in Oncology 2003-01-31
NCT00002639 Suramin in Treating Patients With Recurrent Primary Brain Tumors https://ClinicalTrials.gov/show/NCT00002639 Completed National Cancer Institute (NCI) NA
NCT00004200 Prinomastat Plus Temozolomide Following Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme https://ClinicalTrials.gov/show/NCT00004200 Completed Pfizer 2002-01-31
NCT00003846 Radiation Therapy, Chemotherapy, and Peripheral Stem Cell Transplantation in Treating Patients With Primitive Neuroectodermal Tumors https://ClinicalTrials.gov/show/NCT00003846 Completed Children’s Oncology Group 2004-10-31
NCT00002875 Radiation Therapy Plus Combination Chemotherapy in Treating Children With Medulloblastoma https://ClinicalTrials.gov/show/NCT00002875 Completed Children’s Oncology Group 2006-02-28
NCT00002750 Melphalan in Patients With Neoplastic Meningitis https://ClinicalTrials.gov/show/NCT00002750 Completed Duke University 2001-05-31
NCT00004113 Temozolomide in Treating Patients With Recurrent Malignant Glioma https://ClinicalTrials.gov/show/NCT00004113 Completed Memorial Sloan Kettering Cancer Center 2001-10-31
NCT00003101 Combination Chemotherapy and Bone Marrow Transplantation or Peripheral Stem Cell Transplantation in Treating Patients With Oligodendroglioma https://ClinicalTrials.gov/show/NCT00003101 Completed Memorial Sloan Kettering Cancer Center 2002-01-31
NCT00002876 Etoposide Plus Cisplatin in Treating Patients With Recurrent Ependymomas https://ClinicalTrials.gov/show/NCT00002876 Completed Mayo Clinic 1998-04-30
NCT00004073 Suramin Plus Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme https://ClinicalTrials.gov/show/NCT00004073 Completed Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 2003-05-31
NCT00003876 Internal Radiation Therapy Plus Carmustine Implants in Treating Patients With Recurrent or Refractory Malignant Glioma https://ClinicalTrials.gov/show/NCT00003876 Completed National Cancer Institute (NCI) NA
NCT00003731 Temozolomide in Treating Patients With Recurrent Oligodendroglial Tumors https://ClinicalTrials.gov/show/NCT00003731 Completed European Organisation for Research and Treatment of Cancer - EORTC 2001-01-31
NCT00082797 High-Dose Methotrexate and Leucovorin in Treating Patients With Newly Diagnosed Glioblastoma Multiforme https://ClinicalTrials.gov/show/NCT00082797 Completed Eastern Cooperative Oncology Group 2007-05-31
NCT00003020 LMB-7 Immunotoxin in Treating Patients With Leptomeningeal Metastases https://ClinicalTrials.gov/show/NCT00003020 Completed Duke University 2000-09-30
NCT00002988 Irinotecan Plus Carmustine in Treating Patients With Recurrent Primary Malignant Glioma https://ClinicalTrials.gov/show/NCT00002988 Completed Duke University 2000-11-30
NCT00005081 Carmustine Plus O6-benzylguanine in Treating Patients With Recurrent or Progressive Glioma https://ClinicalTrials.gov/show/NCT00005081 Completed Duke University 2001-04-30
NCT00004892 O6-Benzylguanine and Carmustine Implants in Treating Patients With Recurrent Malignant Glioma https://ClinicalTrials.gov/show/NCT00004892 Completed National Cancer Institute (NCI) NA
NCT00005796 Combination Chemotherapy Plus Gene Therapy in Treating Patients With CNS Tumors https://ClinicalTrials.gov/show/NCT00005796 Completed Indiana University 2003-06-30
NCT00003765 O6-benzylguanine and Carmustine in Treating Children With Refractory CNS Tumors https://ClinicalTrials.gov/show/NCT00003765 Completed National Cancer Institute (NCI) 2006-03-31
NCT00005082 Magnetic Resonance Imaging in Determining Extent of Cancer in Patients With Newly Diagnosed Glioma https://ClinicalTrials.gov/show/NCT00005082 Completed Jonsson Comprehensive Cancer Center 2000-11-30
NCT00003621 Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Anaplastic Astrocytoma https://ClinicalTrials.gov/show/NCT00003621 Completed Alliance for Clinical Trials in Oncology 2005-02-28
NCT00002463 Combination Chemotherapy in Treating Children With Astrocytomas and Primitive Neuroectodermal Tumors https://ClinicalTrials.gov/show/NCT00002463 Completed M.D. Anderson Cancer Center 2007-01-31
NCT00003301 Irinotecan in Treating Patients With Recurrent Malignant Glioma https://ClinicalTrials.gov/show/NCT00003301 Completed National Cancer Institute (NCI) NA
NCT00003176 Temozolomide and Carmustine in Treating Patients With Anaplastic Glioma https://ClinicalTrials.gov/show/NCT00003176 Completed Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 2001-12-03
NCT00002814 Combination Chemotherapy for Patients With Brain Cancer https://ClinicalTrials.gov/show/NCT00002814 Completed Dartmouth-Hitchcock Medical Center 2001-04-30
NCT00022256 Motexafin Gadolinium Plus Radiation Therapy to the Brain in Treating Patients With Newly Diagnosed Glioblastoma Multiforme https://ClinicalTrials.gov/show/NCT00022256 Completed Memorial Sloan Kettering Cancer Center 2003-04-30
NCT00019071 Chemotherapy Followed by Radiation Therapy in Treating Patients With Malignant Glioma https://ClinicalTrials.gov/show/NCT00019071 Completed National Cancer Institute (NCI) NA
NCT00019058 Radiation Therapy in Treating Patients With Glioblastoma https://ClinicalTrials.gov/show/NCT00019058 Completed National Cancer Institute (NCI) NA
NCT00014573 Chemotherapy and Vaccine Therapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation and Interleukin-2 in Treating Patients With Recurrent or Refractory Brain Cancer https://ClinicalTrials.gov/show/NCT00014573 Completed Barbara Ann Karmanos Cancer Institute 2004-10-31
NCT00007813 Peripheral Stem Cell Transplantation Plus Chemotherapy in Treating Patients With Malignant Solid Tumors https://ClinicalTrials.gov/show/NCT00007813 Completed Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 2005-02-01
NCT00006368 Yttrium Y 90 SMT 487 in Treating Patients With Refractory or Recurrent Cancer https://ClinicalTrials.gov/show/NCT00006368 Completed Novartis 2003-11-30
NCT00003657 High-dose ICE With Amifostine https://ClinicalTrials.gov/show/NCT00003657 Completed Dana-Farber Cancer Institute 2000-11-30
NCT00022360 Taurolidine in Treating Patients With Recurrent or Progressive Glioma https://ClinicalTrials.gov/show/NCT00022360 Completed Memorial Sloan Kettering Cancer Center 2001-10-31
NCT00014300 Glufosfamide in Treating Patients With Recurrent Glioblastoma Multiforme https://ClinicalTrials.gov/show/NCT00014300 Completed European Organisation for Research and Treatment of Cancer - EORTC 2001-09-30
NCT00003465 Temozolomide in Treating Patients With Anaplastic Oligodendroglioma https://ClinicalTrials.gov/show/NCT00003465 Completed Duke University NA
NCT00079092 Thalidomide and Procarbazine in Treating Patients With Recurrent or Progressive Malignant Glioma https://ClinicalTrials.gov/show/NCT00079092 Completed Wake Forest University Health Sciences 2006-03-21
NCT00078988 High-Dose Chemotherapy Plus Autologous Stem Cell Transplantation Compared With Intermediate-Dose Chemotherapy Plus Autologous Stem Cell Transplantation With or Without Isotretinoin in Treating Young Patients With Recurrent High-Grade Gliomas https://ClinicalTrials.gov/show/NCT00078988 Completed Children’s Oncology Group 2006-09-30
NCT00006452 Gadolinium Texaphyrin Plus Radiation Therapy in Treating Patients With Supratentorial Glioblastoma Multiforme https://ClinicalTrials.gov/show/NCT00006452 Completed Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 2003-05-09
NCT00002825 Docetaxel in Treating Children With Recurrent Solid Tumors https://ClinicalTrials.gov/show/NCT00002825 Completed National Cancer Institute (NCI) 2004-12-31
NCT00003935 Combination Chemotherapy Plus Radiation Therapy in Treating Children With Newly Diagnosed Brain Stem Glioma https://ClinicalTrials.gov/show/NCT00003935 Completed Children’s Oncology Group 2003-10-31
NCT00003573 Etoposide Plus Radiation Therapy Followed by Combination Chemotherapy in Treating Children With Newly Diagnosed Advanced Medulloblastoma https://ClinicalTrials.gov/show/NCT00003573 Completed Children’s Oncology Group 2007-10-31
NCT00003916 Standard Radiation Therapy With or Without Stereotactic Radiation Therapy in Treating Patients With Glioma https://ClinicalTrials.gov/show/NCT00003916 Completed European Organisation for Research and Treatment of Cancer - EORTC 2001-12-31
NCT00006388 Radiation Therapy and Tamoxifen in Treating Adults With Newly Diagnosed Supratentorial Glioblastoma Multiforme https://ClinicalTrials.gov/show/NCT00006388 Completed Radiation Therapy Oncology Group 2003-10-31
NCT00077207 Carboplatin, Vincristine, and Temozolomide in Treating Children With Progressive and/or Symptomatic Low-Grade Glioma https://ClinicalTrials.gov/show/NCT00077207 Completed Children’s Oncology Group 2010-03-31
NCT00003616 Irinotecan in Treating Patients With Progressive or Recurrent Malignant Glioma https://ClinicalTrials.gov/show/NCT00003616 Completed Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 2002-05-17
NCT00003185 Biological Therapy in Treating Patients With Glioblastoma Multiforme https://ClinicalTrials.gov/show/NCT00003185 Completed National Cancer Institute (NCI) NA
NCT00002840 Radiation Therapy With and Without Combination Chemotherapy in Patients With Resected Anaplastic Oligodendroglioma https://ClinicalTrials.gov/show/NCT00002840 Completed European Organisation for Research and Treatment of Cancer - EORTC 2002-03-31
NCT00075894 Alanosine in Treating Patients With Progressive or Recurrent Malignant Gliomas https://ClinicalTrials.gov/show/NCT00075894 Completed National Cancer Institute (NCI) NA
NCT00006353 Radiation Therapy With or Without Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Multiforme https://ClinicalTrials.gov/show/NCT00006353 Completed European Organisation for Research and Treatment of Cancer - EORTC 2002-03-31
NCT00006080 Fenretinide in Treating Patients With Recurrent Malignant Glioma https://ClinicalTrials.gov/show/NCT00006080 Completed Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 2004-09-14
NCT00074243 CC-8490 in Treating Patients With Recurrent or Refractory High-Grade Gliomas https://ClinicalTrials.gov/show/NCT00074243 Completed National Cancer Institute (NCI) NA
NCT00003409 Motexafin Gadolinium Plus Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme https://ClinicalTrials.gov/show/NCT00003409 Completed National Cancer Institute (NCI) NA
NCT00005813 Bispecific Antibody Plus White Blood Cells in Treating Patients With Recurrent or Refractory Glioblastoma Multiforme https://ClinicalTrials.gov/show/NCT00005813 Completed Dartmouth-Hitchcock Medical Center 2003-01-31
NCT00014677 NBI-3001 Followed by Surgery in Treating Patients With Recurrent Glioblastoma Multiforme https://ClinicalTrials.gov/show/NCT00014677 Completed National Cancer Institute (NCI) 2002-09-30
NCT00003141 Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Infants With Malignant Brain or Spinal Cord Tumors https://ClinicalTrials.gov/show/NCT00003141 Completed Children’s Oncology Group 2007-12-31
NCT00003234 Vinorelbine in Treating Children With Recurrent or Refractory Cancers https://ClinicalTrials.gov/show/NCT00003234 Completed Children’s Oncology Group 2006-03-31
NCT00070161 Phase II Studies Of Donepezil And Ginkgo Biloba In Irradiated Brain Tumor https://ClinicalTrials.gov/show/NCT00070161 Completed Wake Forest University Health Sciences 2005-05-31
NCT00070096 Ixabepilone in Treating Patients With Advanced Cisplatin-Refractory Germ Cell Tumors https://ClinicalTrials.gov/show/NCT00070096 Completed National Cancer Institute (NCI) NA
NCT00069940 Vaccine Therapy and Sargramostim in Treating Patients With Sarcoma or Brain Tumor https://ClinicalTrials.gov/show/NCT00069940 Completed Dana-Farber Cancer Institute 2006-08-31
NCT00003463 Carmustine Wafers Plus Irinotecan in Treating Patients With Recurrent Supratentorial High Grade Gliomas https://ClinicalTrials.gov/show/NCT00003463 Completed Duke University 2002-07-31
NCT00068510 Vaccine Therapy in Treating Patients With Malignant Glioma https://ClinicalTrials.gov/show/NCT00068510 Completed Jonsson Comprehensive Cancer Center 2012-09-30
NCT00068250 Combination Chemotherapy, Monoclonal Antibody, and Radiation Therapy in Treating Patients With Primary Central Nervous System Lymphoma https://ClinicalTrials.gov/show/NCT00068250 Completed Radiation Therapy Oncology Group 2016-12-31
NCT00010036 Carboplatin Plus Irinotecan in Treating Patients With Glioblastoma Multiforme https://ClinicalTrials.gov/show/NCT00010036 Completed NYU Langone Health 2001-10-31
NCT00008086 Calcitriol Plus Carboplatin in Treating Patients With Advanced Solid Tumors https://ClinicalTrials.gov/show/NCT00008086 Completed University of Pittsburgh 2004-09-30
NCT00004004 Procarbazine in Treating Patients With Recurrent Brain Tumor https://ClinicalTrials.gov/show/NCT00004004 Completed National Cancer Institute (NCI) NA
NCT00003464 Temozolomide in Treating Adults With Newly Diagnosed Primary Malignant Glioblastoma Multiforme https://ClinicalTrials.gov/show/NCT00003464 Completed Duke University NA
NCT00066248 Cyproheptadine and Megestrol in Preventing Weight Loss in Children With Cachexia Caused By Cancer or Cancer Treatment https://ClinicalTrials.gov/show/NCT00066248 Completed University of South Florida 2007-08-31
NCT00003712 CCI-779 in Treating Patients With Advanced Solid Tumors https://ClinicalTrials.gov/show/NCT00003712 Completed The University of Texas Health Science Center at San Antonio 2002-06-30
NCT00002965 Interferon Alfa in Treating Patients With Recurrent Unresectable Meningiomas and Malignant Meningiomas https://ClinicalTrials.gov/show/NCT00002965 Completed M.D. Anderson Cancer Center 2003-03-31
NCT00064363 Talampanel in Treating Patients With Recurrent High-Grade Glioma https://ClinicalTrials.gov/show/NCT00064363 Completed National Institutes of Health Clinical Center (CC) NA
NCT00003211 Chemotherapy, Radiation Therapy, and Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Medulloblastoma or Supratentorial Primitive Neuroectodermal Tumor https://ClinicalTrials.gov/show/NCT00003211 Completed St. Jude Children’s Research Hospital 2007-06-30
NCT00036660 SarCNU in Treating Patients With Recurrent Malignant Glioma https://ClinicalTrials.gov/show/NCT00036660 Completed Canadian Cancer Trials Group 2003-04-15
NCT00002752 Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Primary or Metastatic Brain Cancers https://ClinicalTrials.gov/show/NCT00002752 Completed Duke University 2003-01-31
NCT00027612 Irinotecan Plus Radiation Therapy Followed By Chemotherapy in Treating Patients With Glioblastoma Multiforme https://ClinicalTrials.gov/show/NCT00027612 Completed Alliance for Clinical Trials in Oncology 2006-10-31
NCT00004868 SU5416 in Treating Patients With Recurrent Astrocytoma or Mixed Glioma That Has Not Responded to Radiation Therapy https://ClinicalTrials.gov/show/NCT00004868 Completed Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 2004-09-15
NCT00003203 Carboplatin and Vincristine Plus Radiation Therapy Followed By Adjuvant Chemotherapy in Treating Young Patients With Newly Diagnosed CNS Embryonal Tumors https://ClinicalTrials.gov/show/NCT00003203 Completed Children’s Oncology Group 2007-10-31
NCT00004068 Irinotecan Followed by Radiation Therapy and Temozolomide in Treating Children With Newly Diagnosed Brain Tumor https://ClinicalTrials.gov/show/NCT00004068 Completed St. Jude Children’s Research Hospital 2003-04-30
NCT00002971 O(6)-Benzylguanine in Treating Patients With Malignant Glioma https://ClinicalTrials.gov/show/NCT00002971 Completed Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 2003-02-20
NCT00003484 Radiolabeled Monoclonal Antibody Therapy After Radiation Therapy in Treating Patients With Primary Brain Tumors https://ClinicalTrials.gov/show/NCT00003484 Completed Duke University 2003-11-30
NCT00003173 High-Dose Thiotepa Plus Peripheral Stem Cell Transplantation in Treating Patients With Refractory Solid Tumors https://ClinicalTrials.gov/show/NCT00003173 Completed Memorial Sloan Kettering Cancer Center 2003-05-31
NCT00058370 Intrathecal Radioimmunotherapy, Radiation Therapy, and Chemotherapy After Surgery in Treating Patients With Medulloblastoma https://ClinicalTrials.gov/show/NCT00058370 Completed Memorial Sloan Kettering Cancer Center 2019-06-30
NCT00058123 Poly-ICLC in Treating Patients With Recurrent or Progressive Anaplastic Glioma https://ClinicalTrials.gov/show/NCT00058123 Completed Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 2007-10-06
NCT00028678 Dalteparin and Radiation Therapy in Treating Patients With Newly Diagnosed Supratentorial Glioblastoma Multiforme https://ClinicalTrials.gov/show/NCT00028678 Completed Eastern Cooperative Oncology Group 2006-07-31
NCT00053183 Surgery Followed by Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme https://ClinicalTrials.gov/show/NCT00053183 Completed National Cancer Institute (NCI) NA
NCT00053118 Chemotherapy and Stem Cell Transplantation in Treating Children With Central Nervous System Cancer https://ClinicalTrials.gov/show/NCT00053118 Completed Roswell Park Cancer Institute 2004-07-31
NCT00052455 Temozolomide Compared to Procarbazine, Lomustine, and Vincristine in Treating Patients With Recurrent Malignant Glioma https://ClinicalTrials.gov/show/NCT00052455 Completed National Cancer Institute (NCI) NA
NCT00052286 Modafinil in Treating Fatigue and Behavioral Change in Patients With Primary Brain Cancer https://ClinicalTrials.gov/show/NCT00052286 Completed Jonsson Comprehensive Cancer Center 2006-07-31
NCT00049361 Radiation Therapy Plus Thalidomide and Temozolomide in Treating Patients With Newly Diagnosed Brain Metastases https://ClinicalTrials.gov/show/NCT00049361 Completed Wake Forest University Health Sciences 2004-12-07
NCT00049023 Radiolabeled Octreotide in Treating Children With Advanced or Refractory Solid Tumors https://ClinicalTrials.gov/show/NCT00049023 Completed University of Iowa 2011-08-31
NCT00047320 Neoadjuvant Chemotherapy With or Without Second-Look Surgery Followed by Radiation Therapy With or Without Peripheral Stem Cell Transplantation in Treating Patients With Intracranial Germ Cell Tumors https://ClinicalTrials.gov/show/NCT00047320 Completed Children’s Oncology Group 2009-02-28
NCT00047294 Temozolomide, Thalidomide, and Celecoxib Following Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme https://ClinicalTrials.gov/show/NCT00047294 Completed Dana-Farber Cancer Institute 2005-03-31
NCT00047281 Thalidomide, Celecoxib, and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Malignant Glioma https://ClinicalTrials.gov/show/NCT00047281 Completed Dana-Farber Cancer Institute 2005-08-31
NCT00047177 Oxaliplatin in Treating Children With Recurrent or Refractory Medulloblastoma, Supratentorial Primitive Neuroectodermal Tumor, or Atypical Teratoid Rhabdoid Tumor https://ClinicalTrials.gov/show/NCT00047177 Completed Pediatric Brain Tumor Consortium 2004-08-31
NCT00047073 Sirolimus in Treating Patients With Glioblastoma Multiforme https://ClinicalTrials.gov/show/NCT00047073 Completed Jonsson Comprehensive Cancer Center 2005-06-30
NCT00045474 Brachytherapy in Treating Patients With Recurrent Malignant Glioma https://ClinicalTrials.gov/show/NCT00045474 Completed National Cancer Institute (NCI) NA
NCT00040911 Electroacupuncture in Treating Delayed Nausea and Vomiting in Patients Receiving Chemotherapy For Newly Diagnosed Childhood Sarcoma, Neuroblastoma, Nasopharyngeal Cancer, Germ Cell Tumors, or Hodgkin Lymphoma https://ClinicalTrials.gov/show/NCT00040911 Completed Children’s Oncology Group 2009-10-31
NCT00039572 Boron Neutron Capture Therapy in Treating Patients With Glioblastoma Multiforme or Melanoma Metastatic to the Brain https://ClinicalTrials.gov/show/NCT00039572 Completed National Cancer Institute (NCI) NA
NCT00039468 Thalidomide and Irinotecan in Treating Patients With Glioblastoma Multiforme Who Have Undergone Radiation Therapy https://ClinicalTrials.gov/show/NCT00039468 Completed Dartmouth-Hitchcock Medical Center 2007-09-30
NCT00039364 Imatinib Mesylate in Treating Patients With Gliomas https://ClinicalTrials.gov/show/NCT00039364 Completed European Organisation for Research and Treatment of Cancer - EORTC 2004-08-31
NCT00036972 Immunotoxin Therapy Before and After Surgery in Treating Patients With Recurrent Malignant Glioma https://ClinicalTrials.gov/show/NCT00036972 Completed National Cancer Institute (NCI) 2005-01-31
NCT00036959 ABT-751 in Treating Young Patients With Refractory Solid Tumors https://ClinicalTrials.gov/show/NCT00036959 Completed National Institutes of Health Clinical Center (CC) 2010-02-28
NCT00036894 CC-5013 in Treating Patients With Recurrent Glioma https://ClinicalTrials.gov/show/NCT00036894 Completed National Cancer Institute (NCI) NA
NCT00033280 Temozolomide Plus Radiation Therapy in Treating Patients With Newly Diagnosed Anaplastic Oligodendrogliomas or Mixed Anaplastic Oligoastrocytomas https://ClinicalTrials.gov/show/NCT00033280 Completed Radiation Therapy Oncology Group 2005-04-30
NCT00032097 Motexafin Gadolinium in Treating Patients With Glioblastoma Multiforme Who Are Undergoing Radiation Therapy to the Brain https://ClinicalTrials.gov/show/NCT00032097 Completed National Cancer Institute (NCI) NA
NCT00028795 Chemotherapy and Radiation Therapy After Surgery in Treating Children With Newly Diagnosed Astrocytoma, Glioblastoma Multiforme, Gliosarcoma, or Diffuse Intrinsic Pontine Glioma https://ClinicalTrials.gov/show/NCT00028795 Completed Children’s Oncology Group 2007-09-30
NCT00027846 Observation or Radiation Therapy and/or Chemotherapy and Second Surgery in Treating Children Who Have Undergone Surgery for Ependymoma https://ClinicalTrials.gov/show/NCT00027846 Completed Children’s Oncology Group 2010-01-01
NCT00027625 Gefitinib Plus Temozolomide in Treating Patients With Malignant Primary Glioma https://ClinicalTrials.gov/show/NCT00027625 Completed Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 2005-03-17
NCT00025675 Gefitinib in Treating Patients With Recurrent or Progressive CNS Tumors https://ClinicalTrials.gov/show/NCT00025675 Completed Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 2006-07-05
NCT00025558 Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation or Bone Marrow Transplantation in Treating Patients With Brain Cancer https://ClinicalTrials.gov/show/NCT00025558 Completed NYU Langone Health 2007-05-31
NCT00025311 Topotecan in Treating Patients With Recurrent, Progressive, or Refractory Cancer That is Metastatic to the Lining Around the Brain https://ClinicalTrials.gov/show/NCT00025311 Completed NYU Langone Health 2003-10-31
NCT00025077 Combination Chemotherapy, Surgery or Radiation Therapy, and Peripheral Stem Cell Transplant in Treating Patients With Recurrent Medulloblastoma or Primitive Neuroectodermal and Pineal Tumors https://ClinicalTrials.gov/show/NCT00025077 Completed National Cancer Institute (NCI) NA
NCT00024258 Arsenic Trioxide in Treating Patients With Advanced Neuroblastoma or Other Childhood Solid Tumors https://ClinicalTrials.gov/show/NCT00024258 Completed Memorial Sloan Kettering Cancer Center 2009-05-31
NCT00022724 CCI-779 in Treating Patients With Malignant Glioma https://ClinicalTrials.gov/show/NCT00022724 Completed Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 2006-05-04
NCT00020150 Temozolomide and O6-benzylguanine in Treating Children With Solid Tumors https://ClinicalTrials.gov/show/NCT00020150 Completed National Cancer Institute (NCI) NA
NCT00019422 Lobradimil and Carboplatin in Treating Children With Brain Tumors https://ClinicalTrials.gov/show/NCT00019422 Completed National Cancer Institute (NCI) NA
NCT00019019 Carboxyamidotriazole and Paclitaxel in Treating Patients With Advanced Solid Tumors or Refractory Lymphomas https://ClinicalTrials.gov/show/NCT00019019 Completed National Institutes of Health Clinical Center (CC) 2006-07-31
NCT00017264 Atrasentan in Treating Patients With Progressive or Recurrent Malignant Glioma https://ClinicalTrials.gov/show/NCT00017264 Completed National Cancer Institute (NCI) NA
NCT00016991 ZD 1839 in Treating Patients With Glioblastoma Multiforme in First Relapse https://ClinicalTrials.gov/show/NCT00016991 Completed Duke University NA
NCT00015899 SCH 66336 in Treating Children With Recurrent or Progressive Brain Tumors https://ClinicalTrials.gov/show/NCT00015899 Completed Pediatric Brain Tumor Consortium 2005-09-30
NCT00014521 Karenitecin in Treating Patients With Recurrent Malignant Glioma https://ClinicalTrials.gov/show/NCT00014521 Completed National Cancer Institute (NCI) NA
NCT00012038 Chemotherapy in Treating Patients With Progressive or Recurrent Brain Tumors https://ClinicalTrials.gov/show/NCT00012038 Completed National Cancer Institute (NCI) NA
NCT00010049 Imatinib Mesylate in Treating Patients With Recurrent Malignant Glioma or Meningioma https://ClinicalTrials.gov/show/NCT00010049 Completed Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 2005-03-17
NCT00008008 Thiotepa Followed by Peripheral Stem Cell or Bone Marrow Transplant in Treating Patients With Malignant Glioma https://ClinicalTrials.gov/show/NCT00008008 Completed National Cancer Institute (NCI) 2005-06-30
NCT00007982 Chemotherapy Plus Peripheral Stem Cell Transplant in Treating Patients With Central Nervous System Cancer https://ClinicalTrials.gov/show/NCT00007982 Completed National Cancer Institute (NCI) 2005-02-28
NCT00006474 Temozolomide and O6-benzylguanine in Treating Patients With Newly Diagnosed, Recurrent, or Progressive Anaplastic Glioma https://ClinicalTrials.gov/show/NCT00006474 Completed Duke University 2004-08-31
NCT00006386 Radiation Therapy Followed by Carmustine in Treating Patients Who Have Supratentorial Glioblastoma Multiforme https://ClinicalTrials.gov/show/NCT00006386 Completed Radiation Therapy Oncology Group 2004-11-30
NCT00006355 Pyrazoloacridine Followed by Radiation Therapy in Treating Adults With Newly Diagnosed Supratentorial Glioblastoma Multiforme https://ClinicalTrials.gov/show/NCT00006355 Completed Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 2004-10-31
NCT00006268 Immunotoxin Therapy in Treating Patients With Malignant Glioma https://ClinicalTrials.gov/show/NCT00006268 Completed National Cancer Institute (NCI) NA
NCT00006258 Combination Chemotherapy Followed by Radiation Therapy in Treating Patients With Medulloblastoma, Supratentorial Primitive Neuroectodermal Tumor, or Ependymoma https://ClinicalTrials.gov/show/NCT00006258 Completed National Cancer Institute (NCI) NA
NCT00006246 Busulfan in Treating Children and Adolescents With Refractory CNS Cancer https://ClinicalTrials.gov/show/NCT00006246 Completed Pediatric Brain Tumor Consortium 2003-05-31
NCT00006102 Rebeccamycin Analogue in Treating Children With Solid Tumors or Non-Hodgkin’s Lymphoma https://ClinicalTrials.gov/show/NCT00006102 Completed National Cancer Institute (NCI) 2006-06-30
NCT00006093 EMD 121974 in Treating Patients With Progressive or Recurrent Glioma https://ClinicalTrials.gov/show/NCT00006093 Completed National Cancer Institute (NCI) NA
NCT00006025 Temozolomide Plus Irinotecan in Treating Patients With Recurrent Malignant Glioma https://ClinicalTrials.gov/show/NCT00006025 Completed Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 2005-01-10
NCT00006024 Temozolomide Plus Lomustine Followed by Radiation Therapy in Treating Patients With High-Grade Malignant Glioma https://ClinicalTrials.gov/show/NCT00006024 Completed Children’s Oncology Group 2005-01-31
NCT00005976 Pyrazoloacridine Plus Carboplatin in Treating Patients With Recurrent Glioma https://ClinicalTrials.gov/show/NCT00005976 Completed National Cancer Institute (NCI) 2006-12-31
NCT00005955 Temozolomide Followed by Radiation Therapy in Treating Children With Newly Diagnosed Malignant CNS Tumors https://ClinicalTrials.gov/show/NCT00005955 Completed Duke University NA
NCT00005954 Temozolomide in Treating Patients With Brain Metastases https://ClinicalTrials.gov/show/NCT00005954 Completed Duke University NA
NCT00005952 Temozolomide Plus Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Malignant Glioma or Recurrent CNS or Other Solid Tumors https://ClinicalTrials.gov/show/NCT00005952 Completed Duke University 2005-11-30
NCT00005951 Irinotecan Plus Temozolomide in Treating Patients With Recurrent Primary Malignant Glioma https://ClinicalTrials.gov/show/NCT00005951 Completed Duke University 2006-04-30
NCT00005859 Tipifarnib in Treating Patients With Recurrent or Progressive Malignant Glioma https://ClinicalTrials.gov/show/NCT00005859 Completed Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 2005-07-01
NCT00005855 Efaproxiral Plus Carmustine in Treating Patients With Progressive or Recurrent Malignant Glioma https://ClinicalTrials.gov/show/NCT00005855 Completed National Cancer Institute (NCI) NA
NCT00005637 Combination Chemotherapy Following Radiation Therapy in Treating Patients With Malignant Glioma https://ClinicalTrials.gov/show/NCT00005637 Completed National Cancer Institute (NCI) 2003-06-30
NCT00005602 Radiation Therapy Plus Carboplatin and Lobradimil in Treating Children With Newly Diagnosed Brain Stem Gliomas https://ClinicalTrials.gov/show/NCT00005602 Completed Children’s Oncology Group 2005-01-31
NCT00005590 Levofloxacin to Prevent Infection Following Chemotherapy in Treating Patients With Solid Tumors or Lymphoma https://ClinicalTrials.gov/show/NCT00005590 Completed National Cancer Institute (NCI) NA
NCT00004259 Radiation Therapy Combined With Chemotherapy in Treating Patients With Anaplastic Astrocytoma or Mixed Gliomas https://ClinicalTrials.gov/show/NCT00004259 Completed Radiation Therapy Oncology Group 2015-02-01
NCT00004224 Combination Chemotherapy Followed by Radiation Therapy in Treating Children With Localized Ependymoma https://ClinicalTrials.gov/show/NCT00004224 Completed National Cancer Institute (NCI) NA
NCT00004212 DX-8951f in Treating Children With Advanced Solid Tumors or Lymphomas https://ClinicalTrials.gov/show/NCT00004212 Completed Daiichi Sankyo, Inc. 2004-04-30
NCT00004147 COL-3 in Treating Patients With Progressive or Recurrent Brain Tumors https://ClinicalTrials.gov/show/NCT00004147 Completed National Cancer Institute (NCI) NA
NCT00004028 Carmustine in Treating Patients With Recurrent Malignant Glioma https://ClinicalTrials.gov/show/NCT00004028 Completed National Cancer Institute (NCI) NA
NCT00004024 Biological Therapy Following Surgery and Radiation Therapy in Treating Patients With Primary or Recurrent Astrocytoma or Oligodendroglioma https://ClinicalTrials.gov/show/NCT00004024 Completed Barbara Ann Karmanos Cancer Institute 2004-01-31
NCT00004017 Radiolabeled Monoclonal Antibody in Treating Patients With Glioblastoma Multiforme or Anaplastic Astrocytoma https://ClinicalTrials.gov/show/NCT00004017 Completed National Cancer Institute (NCI) NA
NCT00004015 Boron Neutron Capture Therapy Following Surgery in Treating Patients With Glioblastoma Multiforme Removed During Surgery https://ClinicalTrials.gov/show/NCT00004015 Completed European Organisation for Research and Treatment of Cancer - EORTC 2003-07-31
NCT00003478 Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Primary Brain Tumors https://ClinicalTrials.gov/show/NCT00003478 Completed Duke University 2007-07-31
NCT00003467 Carmustine in Treating Adults With Recurrent Supratentorial Low-Grade Glioma https://ClinicalTrials.gov/show/NCT00003467 Completed Duke University NA
NCT00003466 Temozolomide in Treating Patients With Progressive Low-Grade Glioma https://ClinicalTrials.gov/show/NCT00003466 Completed Duke University 2005-07-31
NCT00003462 Intrathecal Busulfan in Treating Patients With Recurrent, Refractory, or Metastatic Leptomeningeal Tumors https://ClinicalTrials.gov/show/NCT00003462 Completed Duke University 2001-02-28
NCT00003461 Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Primary or Metastatic Brain Tumors https://ClinicalTrials.gov/show/NCT00003461 Completed Duke University 2005-02-28
NCT00003417 Computer Planned Radiation Therapy Plus Chemotherapy in Treating Patients With Glioblastoma Multiforme https://ClinicalTrials.gov/show/NCT00003417 Completed Radiation Therapy Oncology Group 2004-05-31
NCT00003375 Observation or Radiation Therapy With or Without Combination Chemotherapy in Treating Patients With Low-Grade Glioma https://ClinicalTrials.gov/show/NCT00003375 Completed Radiation Therapy Oncology Group 2005-08-31
NCT00003309 Combination Chemotherapy Plus Radiation Therapy in Treating Adult Patients With Brain Cancer https://ClinicalTrials.gov/show/NCT00003309 Completed Eastern Cooperative Oncology Group 2004-03-31
NCT00003022 Monoclonal Antibody Therapy in Treating Patients With Leptomeningeal Cancer https://ClinicalTrials.gov/show/NCT00003022 Completed Memorial Sloan Kettering Cancer Center 2005-01-31
NCT00002986 Chemotherapy in Treating Patients With Recurrent Malignant Glioma https://ClinicalTrials.gov/show/NCT00002986 Completed Duke University 2004-05-31
NCT00002944 Combination Chemotherapy in Treating Children With Progressive Brain Tumors https://ClinicalTrials.gov/show/NCT00002944 Completed Children’s Oncology Group 2006-02-28
NCT00002931 Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Relapsed Germ Cell Cancer https://ClinicalTrials.gov/show/NCT00002931 Completed City of Hope Medical Center 2014-12-31
NCT00002608 Combination Chemotherapy and Tamoxifen in Treating Patients With Solid Tumors https://ClinicalTrials.gov/show/NCT00002608 Completed National Cancer Institute (NCI) NA
NCT00002569 Radiation Therapy With or Without Chemotherapy in Treating Patients With Anaplastic Oligodendroglioma https://ClinicalTrials.gov/show/NCT00002569 Completed Radiation Therapy Oncology Group 2005-02-28
NCT00002472 Cisplatin and Etoposide Prior to Radiation Therapy in Treating Patients With CNS Tumors https://ClinicalTrials.gov/show/NCT00002472 Completed Mayo Clinic 2005-08-31
NCT00098761 VNP40101M in Treating Young Patients With Recurrent, Progressive, or Refractory Primary Brain Tumors https://ClinicalTrials.gov/show/NCT00098761 Completed Pediatric Brain Tumor Consortium 2006-10-31
NCT00031928 Mafosfamide in Treating Patients With Progressive or Refractory Meningeal Tumors https://ClinicalTrials.gov/show/NCT00031928 Completed National Cancer Institute (NCI) NA
NCT00002594 Combination Chemotherapy Followed by Bone Marrow and/or Peripheral Stem Cell Transplantation in Treating Patients With Recurrent Medulloblastoma or CNS Germ Cell Tumors https://ClinicalTrials.gov/show/NCT00002594 Completed Children’s Oncology Group 2003-09-30
NCT00030108 Ixabepilone in Treating Young Patients With Solid Tumors or Leukemia That Haven’t Responded to Therapy https://ClinicalTrials.gov/show/NCT00030108 Completed National Institutes of Health Clinical Center (CC) 2010-03-31

Observational Studiess

#If less then 500 studies

nct_id brief_title link overall_status source primary_completion_date
NCT03147989 Retrospective Study of MRI With MULTIHANCE at 0.10 and 0.05 mmol/Kg Dose in CNS Patients https://ClinicalTrials.gov/show/NCT03147989 Completed Bracco Diagnostics, Inc 2017-12-07
NCT03071913 Blood Brain Barrier Differences in Patients With Brain Tumors Undergoing Surgery https://ClinicalTrials.gov/show/NCT03071913 Recruiting Mayo Clinic 2021-03-31
NCT03055364 Cognitive Function After Treatment of Primary CNS Malignancy https://ClinicalTrials.gov/show/NCT03055364 Recruiting Mayo Clinic 2022-06-30
NCT03052738 Medical Marijuana in the Pediatric Central Nervous System Tumor Population https://ClinicalTrials.gov/show/NCT03052738 Recruiting University of Colorado, Denver 2020-12-31
NCT02684838 Vigilant ObservatIon of GlIadeL WAfer ImplaNT Registry https://ClinicalTrials.gov/show/NCT02684838 Recruiting Arbor Pharmaceuticals, Inc. 2023-12-31
NCT02530658 Next Generation Sequencing of Normal Tissues Prospectively in Pediatric Oncology Patients https://ClinicalTrials.gov/show/NCT02530658 Active, not recruiting St. Jude Children’s Research Hospital 2025-07-01
NCT02402244 Project: Every Child for Younger Patients With Cancer https://ClinicalTrials.gov/show/NCT02402244 Recruiting Children’s Oncology Group 2020-12-14
NCT02291822 Retrospective Study of MRI in Pediatric Patients https://ClinicalTrials.gov/show/NCT02291822 Completed Bracco Diagnostics, Inc 2015-12-31
NCT02851706 Natural History of and Specimen Banking for People With Tumors of the Central Nervous System https://ClinicalTrials.gov/show/NCT02851706 Recruiting National Institutes of Health Clinical Center (CC) 2066-06-06
NCT01682824 Three-Factor Eating Questionnaire in Measuring Eating Behavior in Adolescent and Young Adult Survivors of CNS Tumors https://ClinicalTrials.gov/show/NCT01682824 Active, not recruiting M.D. Anderson Cancer Center 2024-05-31
NCT01585389 Studying Gene Expression and Location in Samples From Patients With Brain Tumors https://ClinicalTrials.gov/show/NCT01585389 Completed Children’s Oncology Group 2016-05-31
NCT01553175 Studying Gene Expression in Samples From Patients With Rhabdoid Tumors https://ClinicalTrials.gov/show/NCT01553175 Completed Children’s Oncology Group 2016-07-31
NCT01474174 Trivalent Influenza Vaccine in Preventing Flu in Patients With Central Nervous System Tumors https://ClinicalTrials.gov/show/NCT01474174 Completed Wake Forest University Health Sciences 2012-07-31
NCT01353300 Gene Mutation in Samples From Young Patients With Pleuropulmonary Blastoma Syndrome at Risk for Developing Cancer https://ClinicalTrials.gov/show/NCT01353300 Completed Children’s Oncology Group 2016-07-31
NCT04296617 Assessment of LET-Based Models and Changes Seen on Brain Imaging in Pediatric Patients Following Proton Therapy for Primary Central Nervous System or Base of Skull Tumors https://ClinicalTrials.gov/show/NCT04296617 Recruiting Mayo Clinic 2020-06-21
NCT04081701 68-Ga DOTATATE PET/MRI in the Diagnosis and Management of Somatostatin Receptor Positive CNS Tumors. https://ClinicalTrials.gov/show/NCT04081701 Recruiting Weill Medical College of Cornell University 2021-08-30
NCT03750188 Evaluation of Safety and Efficacy of ProHance in Pediatric Patients <2yrs https://ClinicalTrials.gov/show/NCT03750188 Completed Bracco Diagnostics, Inc 2019-09-17
NCT01180881 Neurobehavioral Functioning in Pediatric Brain Tumor Patients After Proton Beam Radiation Treatment https://ClinicalTrials.gov/show/NCT01180881 Active, not recruiting Massachusetts General Hospital 2020-08-31
NCT01067196 Outcomes Study of Late Effects After Proton RT for Pediatric Tumors of the Brain, Head, and Neck https://ClinicalTrials.gov/show/NCT01067196 Active, not recruiting University of Florida 2015-12-31
NCT01009307 Study of Blood and Cheek Cell Samples From Patients With Glioma https://ClinicalTrials.gov/show/NCT01009307 Completed University of California, San Francisco 2006-07-31
NCT01004887 Study of Tissue and Blood Samples From Patients With High-Grade Glioma https://ClinicalTrials.gov/show/NCT01004887 Completed Alliance for Clinical Trials in Oncology 2014-12-31
NCT01004523 Study of Tissue and Blood Samples From Patients With Low-Grade Glioma https://ClinicalTrials.gov/show/NCT01004523 Completed Alliance for Clinical Trials in Oncology 2013-03-31
NCT00999622 Study of Blood Samples and Risk of Infection in Patients With Newly Diagnosed Malignant Supratentorial Astrocytoma https://ClinicalTrials.gov/show/NCT00999622 Completed Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 2009-08-31
NCT00920738 Metabolic Syndrome in Childhood Cancer Survivors https://ClinicalTrials.gov/show/NCT00920738 Completed University of Minnesota 2010-07-31
NCT00899834 DNA Analysis of Tumor Tissue Samples From Patients With Diffuse Brain Stem Glioma https://ClinicalTrials.gov/show/NCT00899834 Completed St. Jude Children’s Research Hospital 2015-08-31
NCT00897663 Improving the Selection of Patients With Glioblastoma Multiforme for Treatment With Epidermal Growth Factor Receptor Inhibitor Therapies https://ClinicalTrials.gov/show/NCT00897663 Completed Alliance for Clinical Trials in Oncology 2018-01-31
NCT00897286 Study of Stored Tumor Samples in Young Patients With Brain Tumors https://ClinicalTrials.gov/show/NCT00897286 Recruiting St. Jude Children’s Research Hospital 2026-02-28
NCT00890435 Decision Making About Participating in Pharmacokinetic Studies in Patients Enrolled in a Phase I Treatment Clinical Trial https://ClinicalTrials.gov/show/NCT00890435 Completed Children’s Oncology Group 2009-08-31
NCT00822432 Coproporphyrine Isomers and Methotrexate Elimination https://ClinicalTrials.gov/show/NCT00822432 Completed Assistance Publique - Hôpitaux de Paris 2011-08-31
NCT01445288 Exploratory Study of Effects of Radiation Therapy in Pediatric Patients With Central Nervous System Tumors https://ClinicalTrials.gov/show/NCT01445288 Completed National Institutes of Health Clinical Center (CC) NA
NCT02559752 Computer-based Neurocognitive Assessment in Children With Central Nervous System Tumors Receiving Proton Beam Radiation Therapy https://ClinicalTrials.gov/show/NCT02559752 Recruiting Washington University School of Medicine 2021-03-31
NCT00683319 Observing Young Patients With Ependymoma Undergoing Standard Combination Chemotherapy https://ClinicalTrials.gov/show/NCT00683319 Active, not recruiting National Cancer Institute (NCI) 2034-03-31
NCT00499798 Changes in Semen or Sperm Caused by Temozolomide in Patients With Newly Diagnosed, Progressive, or Recurrent Primary Malignant Brain Tumors https://ClinicalTrials.gov/show/NCT00499798 Completed Wake Forest University Health Sciences 2009-06-30
NCT00340054 Developing Interview Questions to Estimate Workplace Exposure to Electric and Magnetic Fields https://ClinicalTrials.gov/show/NCT00340054 Completed National Institutes of Health Clinical Center (CC) NA
NCT00255671 Acute Side Effects in Patients Who Are Undergoing Stereotactic Radiosurgery for Brain Tumors or Other Brain Disorders https://ClinicalTrials.gov/show/NCT00255671 Completed Case Comprehensive Cancer Center 2008-04-30
NCT00253669 Risk Factors for Developing a Blood Clot in Patients Who Are Undergoing Cancer Treatment for Newly Diagnosed Gliomas https://ClinicalTrials.gov/show/NCT00253669 Completed Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 2009-08-31
NCT00165542 A-protein Levels in Adult and Pediatric Brain Tumor Patients https://ClinicalTrials.gov/show/NCT00165542 Completed Dana-Farber Cancer Institute 2004-02-29
NCT00006342 Genetic Study in Patients Receiving Treatment for Hodgkin’s Disease or Childhood Brain Tumor https://ClinicalTrials.gov/show/NCT00006342 Completed Duke University 2000-09-30
NCT00002485 Development of Strategies to Increase Enrollment in Clinical Trials for Children With Cancer https://ClinicalTrials.gov/show/NCT00002485 Completed Children’s Oncology Group 2003-07-31
NCT00010114 Genetic Study of Newly Diagnosed Central Nervous System Tumors in Young Children https://ClinicalTrials.gov/show/NCT00010114 Completed Pediatric Brain Tumor Consortium 2003-03-31
NCT00003096 Gene Testing to Help in the Diagnosis and Treatment of Childhood Brain Tumors https://ClinicalTrials.gov/show/NCT00003096 Completed Children’s Oncology Group 2006-03-31

Registries

#If less then 500 registries

nct_id brief_title link overall_status source primary_completion_date
NCT04351035 National Wide Cross-sectional Study in Paediatric Central Nervous System Tumours in China – the CNOG-MC001 Registry https://ClinicalTrials.gov/show/NCT04351035 Active, not recruiting Xinhua Hospital, Shanghai Jiao Tong University School of Medicine 2019-06-24
NCT03452774 SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry https://ClinicalTrials.gov/show/NCT03452774 Recruiting Massive Bio, Inc. 2021-12-31